UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant x Filed by a Party other than the Registrant ¨
Check the appropriate box:
¨ | Preliminary Proxy Statement |
¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
x | Definitive Proxy Statement |
¨ | Definitive Additional Materials |
¨ | Soliciting Material Pursuant to §240.14a-12 |
Owens & Minor Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
x | No fee required. |
¨ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
(1) | Title of each class of securities to which the transaction applies: |
(2) | Aggregate number of securities to which the transaction applies: |
(3) | Per unit price or other underlying value of the transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
(4) | Proposed maximum aggregate value of the transaction: |
(5) | Total fee paid: |
¨ | Fee paid previously with preliminary materials. |
¨ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
(1) | Amount Previously Paid: |
(2) | Form, Schedule or Registration Statement No.: |
(3) | Filing Party: |
(4) | Date Filed: |
Notice of
2015
Annual Meeting
and
Proxy Statement
WHETHER OR NOT YOU PRESENTLY PLAN TO ATTEND THE MEETING IN
PERSON, THE BOARD OF DIRECTORS URGES YOU TO VOTE.
Owens & Minor, Inc.
9120 Lockwood Boulevard
Mechanicsville, Virginia 23116
9120 Lockwood Boulevard Mechanicsville, Virginia 23116 (804) 723-7000 |
March 18, 2015
Dear Shareholders:
It is a pleasure to invite you to our Annual Meeting of Shareholders on Thursday, April 30, 2015 at 10:00 a.m. The meeting will be held at the corporate headquarters of Owens & Minor, Inc., 9120 Lockwood Boulevard, Mechanicsville, Virginia 23116. Directions to our offices are on the last page of the proxy statement.
The Notice of 2015 Annual Meeting of Shareholders and Proxy Statement describe the items of business for the meeting. In addition to considering these matters, we will review significant accomplishments and events since our last shareholders meeting as well as future opportunities and initiatives we intend to pursue. Our Board of Directors and management team will be there to discuss items of interest and to answer any questions.
The Notice of 2015 Annual Meeting of Shareholders contains instructions on how to access our proxy materials and our 2014 Annual Report/Form 10-K over the Internet as well as how shareholders can receive paper copies of such documents, if they so desire.
You may vote your shares by the Internet or by telephone or, if you prefer, you may request paper copies of the proxy materials and submit your vote by mail by following the instructions on the proxy card. We encourage you to vote via the Internet. Whichever method you choose, your vote is important so please vote as soon as possible. All of us at Owens & Minor appreciate your continued interest and support.
Warm regards,
CRAIG R. SMITH
Executive Chairman and
Chairman of the Board
Proxy Statement | ||||
Page | ||||
i | ||||
1 | ||||
3 | ||||
5 | ||||
6 | ||||
6 | ||||
8 | ||||
10 | ||||
10 | ||||
11 | ||||
11 | ||||
Proposal 2: Approval of the Proposed Owens & Minor, Inc. 2015 Stock Incentive Plan |
16 | |||
Proposal 3: Ratification Of Independent Registered Public Accounting Firm |
22 | |||
22 | ||||
23 | ||||
25 | ||||
25 | ||||
25 | ||||
26 | ||||
26 | ||||
27 | ||||
27 | ||||
44 | ||||
45 | ||||
48 | ||||
50 | ||||
51 | ||||
51 | ||||
52 | ||||
53 | ||||
54 | ||||
Proposal 4: Advisory Shareholder Vote on Executive Compensation |
58 | |||
58 | ||||
59 | ||||
60 | ||||
Appendix A Proposed Owens & Minor, Inc. 2015 Stock Incentive Plan |
A-1 | |||
B-1 |
YOUR VOTE IS IMPORTANT
Whether or not you plan to attend the annual meeting, please vote your shares promptly, as instructed in the Notice of Internet Availability of Proxy Materials, by the Internet or by telephone. You may also request a paper proxy card to submit your vote by mail, if you prefer. We encourage you to vote via the Internet.
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
To Be Held Thursday, April 30, 2015
TO THE SHAREHOLDERS OF OWENS & MINOR, INC.:
The Annual Meeting of Shareholders of Owens & Minor, Inc. (the Company or Owens & Minor) will be held on Thursday, April 30, 2015 at 10:00 a.m. at the offices of Owens & Minor, 9120 Lockwood Boulevard, Mechanicsville, Virginia.
The purposes of the meeting are:
1. | To elect the eleven directors named in the attached proxy statement, each for a one-year term and until their respective successors are elected and qualified; |
2. | To approve the proposed 2015 Owens & Minor, Inc. Stock Incentive Plan; |
3. | To ratify the appointment of KPMG LLP as the Companys independent registered public accounting firm for the year ending December 31, 2015; |
4. | To conduct an advisory vote on the compensation of our named executive officers; and |
5. | To transact any other business properly before the annual meeting. |
Shareholders of record as of March 5, 2015 will be entitled to vote at the annual meeting.
Your attention is directed to the attached proxy statement. The Notice of Internet Availability of Proxy Materials is being distributed on or about March 18, 2015. This proxy statement, the proxy card and Owens & Minors 2014 Annual Report/Form10-K are being furnished on the Internet on or about March 18, 2015.
BY ORDER OF THE BOARD OF DIRECTORS
GRACE R. DEN HARTOG
Senior Vice President, General Counsel
& Corporate Secretary
i
Street Address |
Mailing Address | |
9120 Lockwood Boulevard | P.O. Box 27626 | |
Mechanicsville, Virginia 23116 | Richmond, Virginia 23261-7626 |
PROXY STATEMENT
Annual Meeting of Shareholders
to be held on April 30, 2015
What You Are Voting On
Proxies are being solicited by the Board of Directors for purposes of voting on the following proposals and any other business properly brought before the meeting:
Proposal 1: | Election of the eleven directors named in this proxy statement, each for a one-year term and until their respective successors are elected and qualified. |
Proposal 2: | Approval of the proposed Owens & Minor, Inc. 2015 Stock Incentive Plan. |
Proposal 3: | Ratification of KPMG LLP as the Companys independent registered public accounting firm for the year ending December 31, 2015. |
Proposal 4: | Advisory vote on the compensation of our named executive officers (NEOs). |
Who is Entitled to Vote
Shareholders of Owens & Minor, Inc. (the Company or Owens & Minor) as of the close of business on March 5, 2015 (the Record Date) are entitled to vote. Each share of the Companys common stock (Common Stock) is entitled to one vote. As of March 5, 2015, 63,134,439 shares of Common Stock were issued and outstanding.
How to Vote
You can vote by the Internet, by telephone or by mail.
By Internet. You may vote by the Internet by following the specific instructions on the Notice of Internet Availability of Proxy Materials. Shareholders who have requested a paper copy of a proxy card by mail may submit proxies over the Internet by following the instructions on the proxy card. We encourage you to vote via the Internet. If your shares are held by your bank or broker in street name, please refer to the instruction form that you receive from your bank or broker or contact your bank or broker to determine whether you will be able to vote by the Internet.
By Telephone. You may vote by telephone by calling the toll-free number on the proxy card and following the instructions. Shareholders will need to have the control number that appears on their notice available when voting. If your shares are held by your bank or broker in street name, please refer to the instruction form that you receive from your bank or broker or contact your bank or broker to determine whether you will be able to vote by telephone.
1
By Mail. Shareholders who have requested a paper copy of a proxy card by mail may submit proxies by completing, signing and dating the enclosed proxy card and returning it in the postage-paid envelope provided.
However you choose to vote, you may revoke a proxy prior to the meeting by (1) submitting a subsequently dated proxy by any of the methods described above, (2) giving notice in writing to the Corporate Secretary of the Company or (3) voting in person at the meeting (attendance at the meeting will not itself revoke a proxy).
What Happens if You Do Not Make Selections on Your Proxy
If your proxy contains specific voting instructions, those instructions will be followed. However, if you sign and return your proxy card by mail or submit your proxy by telephone or via the Internet without making a selection on one or more proposals, you give authority to the individuals designated on the proxy card to vote on the proposal(s) for which you have not made specific selections or given instructions and any other matter that may arise at the meeting. If no specific selection is made or instructions given, it is intended that all proxies that are signed and returned or submitted via telephone or Internet will be voted FOR the election of all nominees for director, FOR approval of the 2015 Stock Incentive Plan, FOR the ratification of KPMG LLP as our independent registered public accounting firm in 2015, and FOR the approval, on an advisory basis, of the compensation of our NEOs.
Whether Your Shares Will be Voted if You Dont Provide Your Proxy
Whether your shares will be voted if you do not provide your proxy depends on how your ownership of shares of Common Stock is registered. If you own your shares as a registered holder, which means that your shares of Common Stock are registered in your name, and you do not provide your proxy, your shares will not be represented at the meeting, will not count toward the quorum requirement, which is explained below, and will not be voted.
If you own your shares of Common Stock in street name, your shares may be voted even if you do not provide your broker with voting instructions. Brokers have the authority under New York Stock Exchange (NYSE) rules to vote shares for which their beneficial owner customers do not provide voting instructions on certain routine matters. When a proposal is not a routine matter and the brokerage firm has not received voting instructions from the beneficial owner of the shares with respect to that proposal, the brokerage firm cannot vote the shares on that proposal. This is called a broker non-vote.
The Company believes that only the proposal to ratify the appointment of KPMG LLP as the Companys independent registered public accounting firm for 2015 is a routine matter for which brokerage firms will have discretionary voting power if you do not give voting instructions with respect to this proposal. The proposal to elect directors, the proposal to approve the 2015 Stock Incentive Plan, as well as the proposal to approve, on an advisory basis, the compensation of our NEOs are non-routine matters for which brokerage firms will not have discretionary voting power and for which specific voting instructions from their customers are required. As a result, brokerage firms will not be allowed to vote on these non-routine matters on behalf of their customers if the customers do not return specific voting instructions.
What Constitutes a Quorum
A majority of the outstanding shares of Common Stock present or represented by proxy constitutes a quorum. A quorum is required to conduct the annual meeting. If you vote your proxy, you will be considered part of the quorum. Abstentions and shares held by brokers or banks in street name (broker shares) that are voted on any matter are included in the quorum. Broker shares that are not voted on any matter will not be included in determining whether a quorum is present.
2
The Vote Required to Approve Each Item
Election of Directors. The affirmative vote of a majority of the votes cast at the meeting is required for the election of each director. A majority of votes cast means that the number of votes cast FOR a nominees election must exceed the number of votes cast AGAINST that nominees election. Abstentions and broker non-votes will not be counted as votes cast and will have no effect on the results of this vote.
Approval of 2015 Stock Incentive Plan. Approval of the 2015 Stock Incentive Plan requires the affirmative vote of a majority of the votes cast on this proposal. Abstentions will be considered as votes cast under the rules of the NYSE and will have the effect of a vote against this proposal for purposes of the rules of the NYSE. Broker non-votes will not be counted as votes cast on this proposal and will have no effect on the results of this vote.
Ratification of Appointment of KPMG LLP. The appointment of KPMG LLP will be ratified if the votes cast FOR this proposal exceed the number of votes cast AGAINST this proposal. Abstentions and broker non-votes will have no effect on the results of this vote.
Advisory Vote on Executive Compensation. The compensation of our executive officers named in the Summary Compensation Table will be approved on an advisory basis if the votes cast FOR this proposal exceed the number of votes cast AGAINST this proposal. Abstentions and broker non-votes will have no effect on the results of this vote.
How to Obtain a Paper Copy of the Proxy Materials
Shareholders will find instructions about how to obtain a paper copy of the proxy materials on the notice they received in the mail about the Internet availability of proxy materials.
What it Means if You Get More Than One Notice about the Internet Availability of Proxy Materials
Your shares are probably registered differently or are held in more than one account. Please vote all proxies to ensure that all your shares are voted. Also, please have all of your accounts registered in the same name and address. You may do this by contacting our transfer agent, Computershare Shareowner Service, LLC, at 1-866-
252-0358.
Costs of Soliciting Proxies
Owens & Minor will pay all costs of this proxy solicitation. The Company has retained Georgeson, Inc. to aid in the distribution and solicitation of proxies for approximately $6,000 plus expenses. The Company will reimburse brokers and other custodians, nominees and fiduciaries for their expenses in forwarding proxy and solicitation materials.
General. The Company is managed under the direction of the Board of Directors, which has adopted Corporate Governance Guidelines to set forth certain corporate governance practices. Each year, we review our corporate governance policies and practices relative to applicable laws, including the Dodd-Frank Wall Street Reform Act and the Sarbanes-Oxley Act of 2002 and rules promulgated thereunder or adopted by the Securities and Exchange Commission (SEC) and the NYSE, the exchange on which the Common Stock is listed, as well as the policies and practices recommended by groups and authorities active in corporate governance.
Corporate Governance Materials. The Companys Bylaws, Corporate Governance Guidelines, Code of Honor and the charters of the Audit, Compensation & Benefits, and Governance & Nominating Committees are
3
available on our website at http://www.owens-minor.com under Corporate Governance. The information available on, or that can be accessed through, our website is not a part of, or incorporated by reference into, this proxy statement.
Code of Honor. The Board of Directors has adopted a Code of Honor that is applicable to all employees of the Company, including the principal executive officer, the principal financial officer and the principal accounting officer, as well as the members of the Board of Directors. We intend to post any amendments to or waivers from our Code of Honor (to the extent applicable to the Companys principal executive officer, principal financial officer, principal accounting officer, any other executive officer or any director) on our website.
Director Independence. The Board of Directors has determined that the following Board members and/or nominees are independent within the meaning of the NYSE listing standards and the Companys Corporate Governance Guidelines: Stuart M. Essig, John W. Gerdelman, Lemuel E. Lewis, Martha H. Marsh, Eddie N. Moore, Jr., James E. Rogers, David S. Simmons, Robert C. Sledd and Anne Marie Whittemore. To assist it in making determinations of independence, the Board has adopted categorical standards which are included in the Companys Corporate Governance Guidelines available on our website at http://www.owens-minor.com under Corporate Governance. The Board has determined that all directors and/or nominees identified as independent in this proxy statement meet these standards.
Structure and Leadership of the Board. The Board of Directors has no policy with respect to the separation of the offices of Chairman of the Board and the Chief Executive Officer. Instead, the Board believes that it is in the best interests of the Company for this determination to be made as part of the succession planning process when it selects a new Chief Executive Officer. The Board selected Craig R. Smith, our Chief Executive Officer until he stepped down effective September 1, 2014, to also serve as Chairman of the Board. This decision was based on the Boards desire to preserve continuity in the operation of the Board, the pursuit of our strategic goals and our unique corporate culture. The Board believes that the role of its independent lead director preserves and maintains the appropriate level of Board independence, consistent with corporate governance best practices. The Companys Corporate Governance Guidelines provide for the annual election of an independent lead director to, among other things, preside at Board meetings in the absence of the Chairman, preside at meetings of the independent directors, serve as principal liaison on behalf of the independent directors and advise the Chairman and the board committee chairmen with respect to agendas and information requirements relating to the Board and committee meetings. The Board believes that the independent lead director enhances communications between board members (including the Chairman) and committees as well as the overall functioning of the Boards leadership.
Majority Vote Requirement for Election of Directors. The Board of Directors amended the Companys Bylaws and Corporate Governance Guidelines in February 2015 to provide for the election of directors by majority, rather than plurality, vote in uncontested elections. The majority vote requirement will be in effect for the 2015 Annual Meeting of Shareholders. Under the Companys Corporate Governance Guidelines, with respect to director nominations, the Board will only nominate those incumbent directors who submit irrevocable resignations effective upon the failure of such director nominee to receive the required vote for re-election and Boards acceptance of such resignation. In the event an incumbent director fails to receive a majority of the votes cast, the Governance & Nominating Committee (or such other committee designated by the Board) will make a recommendation to the Board as to whether to accept or reject the resignation. The Board must act on the resignation, taking into account the Governance & Nominating Committees recommendation, and publicly disclose its decision regarding the resignation, including, if applicable, its rationale for rejecting a resignation, in a press release and an appropriate disclosure with the SEC within 90 days following certification of the election results. The Governance & Nominating Committee in making its recommendation, and the Board in making its decision, may each consider any factors or other information that it considers appropriate and relevant.
The Boards Role in Risk Oversight. The Board of Directors currently administers its risk oversight function through the full Board and not through a separate risk committee of the Board. However, each of the
4
Audit Committee, the Compensation & Benefits Committee and the Governance & Nominating Committee oversees the specific financial, compensation and governance risks, respectively, relating to its functions and responsibilities and reports on these matters to the full Board. The Board performs its risk oversight function through regular reporting by the Board committees as well as the officers and management-level personnel who supervise the day-to-day risk management activities of the Company.
Risk Assessment of Compensation Programs. With respect to our overall compensation programs, Company management has reviewed our compensation policies and practices to determine whether they create risks that are reasonably likely to have a material adverse effect on the Company. As part of this assessment, we reviewed the design and features of our compensation and benefits programs and policies, potential risks that could be created by these programs and features of our programs and corporate governance policies that help to mitigate risk. Management reviewed and discussed the results of the assessment with the Compensation & Benefits Committee. Based on this review, we believe that our compensation policies and practices do not create risks that are reasonably likely to have a material adverse effect on the Company.
REPORT OF THE GOVERNANCE & NOMINATING COMMITTEE
The Governance & Nominating Committee is composed of five directors, all of whom are independent. The Governance & Nominating Committee met four times during 2014, in which considerable time and attention was devoted to executive succession planning as Mr. Smith transitioned from Chief Executive Officer to Executive Chairman and Mr. Bierman was appointed to the role of President and Chief Executive Officer of the Company effective September 1, 2014. During 2014, the Committee also addressed several corporate governance matters, including the decision to allow the existing shareholders rights plan to lapse upon expiration in April 2014 without replacement. At the recommendation of the Governance & Nominating Committee, the Board amended the Companys Bylaws and Corporate Governance Guidelines to provide for the election of directors by majority vote in uncontested elections. Following the election of directors at the Annual Meeting, upon the recommendation of the Committee, the Board appointed new committee chairs and Lead Director and rotated committee memberships. The Committee also adopted a new approach to the 2014 Board self-assessment process with the engagement of an independent outside board consultant. The consultant interviewed all directors to identify strengths and weaknesses and opportunities for improvement of board and board committee structure and function, followed by an executive session with the Board to discuss the results of the assessment. As provided in its charter, the Governance & Nominating Committee reviewed and approved the Committees charter and the Companys Corporate Governance Guidelines; reviewed the performance of the Chief Executive Officer; and reviewed with the Chief Executive Officer proposed organization changes and related management promotions, as well as succession plans for members of senior management.
THE GOVERNANCE & NOMINATING
COMMITTEE
Martha H. Marsh, Chairman
Lemuel E. Lewis
Eddie N. Moore, Jr.
James E. Rogers
Robert C. Sledd
5
The Board of Directors held eleven meetings during 2014. All directors attended at least 75% of the meetings of the Board and committees on which they served. The Companys Corporate Governance Guidelines provide that, absent unusual or unforeseen circumstances, directors are expected to attend each annual meeting of shareholders. All directors attended the 2014 Annual Meeting of Shareholders.
Under the Companys Corporate Governance Guidelines, the independent directors meet in executive session after each regularly scheduled Board meeting. These meetings are chaired by a lead director who is elected annually by the non-management directors following each annual meeting of shareholders. Anne Marie Whittemore was appointed in 2014 to serve as lead director and preside over these executive sessions. As lead director, Ms. Whittemore is also invited to participate in meetings of all Board committees but is permitted to vote only in meetings of committees of which she is a member. Shareholders and other interested parties may contact the lead director by following the procedures set forth in Communications with the Board of Directors on page 10 of this proxy statement.
The Board of Directors currently has the following committees, which the Board established to assist it with its responsibilities:
Audit Committee: Oversees (i) the integrity of the Companys financial statements, (ii) the Companys compliance with legal and regulatory requirements, (iii) the qualification and independence of the Companys independent registered public accounting firm, (iv) the performance of the Companys independent registered public accounting firm and internal audit functions and (v) issues involving the Companys ethical and legal compliance responsibilities. The Audit Committee has sole authority to appoint, retain, compensate, evaluate and terminate the Companys independent registered public accounting firm. The Board of Directors has determined that each of Lemuel E. Lewis and Eddie N. Moore, Jr. is an audit committee financial expert, as defined by SEC regulations and that each member of the Audit Committee is financially literate under NYSE listing standards. All members of the Audit Committee are independent as such term is defined under the enhanced independence standards for audit committees in the Securities Exchange Act of 1934 (the Exchange Act) and the rules thereunder as incorporated into the NYSE listing standards and under the Companys corporate governance guidelines.
Compensation & Benefits Committee: Administers executive compensation programs, policies and practices. Advises the Board on salaries and compensation of the executive officers and makes other studies and recommendations concerning compensation and compensation policies. May delegate authority for day-to-day administration and interpretation of compensation plans to certain senior officers of the Company (other than for matters affecting executive officer compensation and benefits). For further information on this committees processes and procedures, see Compensation Discussion and Analysis on page 27 of this proxy statement. All members of the Compensation & Benefits Committee are independent within the meaning of the enhanced NYSE listing standards and the Companys Corporate Governance Guidelines.
Governance & Nominating Committee: Considers and recommends nominees for election as directors and officers and nominees for each Board committee. Reviews and recommends changes to director compensation. Reviews and evaluates the procedures, practices and policies of the Board and its members and leads the Board in its annual self-review. Oversees the governance of the Company, including reviewing and recommending changes to the Corporate Governance Guidelines. Conducts succession planning for senior management. All members of the Governance & Nominating Committee are independent within the meaning of the NYSE listing standards and the Companys Corporate Governance Guidelines.
Executive Committee: Exercises limited powers of the Board when the Board is not in session.
6
The Company has previously had a Strategic Planning Committee whose purpose was to review and makes recommendations for the strategic direction of the Company and conduct an annual strategic planning retreat for the Board of Directors and senior management. However, we decided to eliminate the Strategic Planning Committee during 2014 since the full board typically performs the strategic planning function for the Company.
BOARD COMMITTEE MEMBERSHIP
Director | Board | Audit |
Compensation & Benefits |
Executive | Governance & Nominating |
Strategic Planning | ||||||
James L. Bierman |
X | X | X | |||||||||
Stuart M. Essig |
X | X | X | |||||||||
John W. Gerdelman |
X | X | X* | |||||||||
Lemuel E. Lewis |
X | X* | X | X | ||||||||
Martha H. Marsh |
X | X | X | X* | X | |||||||
Eddie N. Moore, Jr. |
X | X | X | |||||||||
James E. Rogers |
X | X | X | X | X | |||||||
David S. Simmons |
X | X | X | |||||||||
Robert C. Sledd |
X | X* | X | X | ||||||||
Craig R. Smith |
X* | X* | X | |||||||||
Anne Marie Whittemore |
X | X | ||||||||||
No. of meetings in 2014 |
11 | 6 | 5 | 1 | 4 | 1 |
*Chairman
7
The Governance & Nominating Committee reviews director compensation annually, and it is the responsibility of this committee to recommend to the Board of Directors any changes in director compensation. The Board of Directors makes the final determination with respect to director compensation. The Governance & Nominating Committee has the authority under its charter to retain outside consultants or advisors to assist it in gathering information and making decisions. In 2014, based upon a review of competitive market practices, the Governance & Nominating Committee increased the annual cash retainer paid to non-employee directors from $30,000 to $35,000 and increased the annual equity retainer granted to non-employee directors from $90,000 to $100,000. In addition, the cash retainer paid to our lead director increased from $30,000 to $35,000.
The Company uses a combination of cash and equity compensation to attract and retain qualified candidates to serve on its Board of Directors. In setting director compensation, the Company considers the commitment of time directors must make in performing their duties, the level of skills required by the Company of its Board members and the market competitiveness of its director compensation levels. The table below sets forth the schedule of fees paid to non-employee directors for their annual retainer and service in various capacities on Board committees and in Board leadership roles. Employee directors do not receive any additional compensation other than their normal salary for serving on the Board or any of its committees.
Schedule of Director Fees
Type of Fee | Cash | Equity | ||||||
Annual Retainer |
$ | 35,000 | $ | 100,000 | (1) | |||
Additional Retainer for Lead Director |
35,000 | |||||||
Additional Retainer for Audit Committee Chair |
10,000 | |||||||
Additional Retainer for Compensation & Benefits Committee Chair |
10,000 | |||||||
Additional Retainer for Governance & Nominating Committee Chair |
9,000 | |||||||
Additional Retainer for Other Committee Chairs |
8,000 | |||||||
Board or Audit Committee Attendance Fee (per meeting) |
2,000 | |||||||
Compensation & Benefits Committee Attendance Fee |
1,800 | |||||||
Other Committee Attendance Fee (per meeting) |
1,500 | |||||||
Board or Committee Telephone Conference (per meeting, other than Audit Committee) |
1,000 | |||||||
Audit Committee Telephone Conference (per meeting) |
1,200 | |||||||
Board Retreat (annual 2-day meeting) |
3,000 |
(1) Restricted stock grant with one-year vesting period.
Directors may defer the receipt of all or part of their director fees under the Directors Deferred Compensation Plan. Amounts deferred are invested in bookkeeping accounts that measure earnings and losses based on the performance of a particular investment. Directors may elect to defer their fees into the following two subaccounts: (i) an account based upon the price of the Common Stock and (ii) an account based upon the current interest rate of the Companys fixed income fund in its 401(k) plan. Subject to certain restrictions, a director may take cash distributions from a deferred fee account either prior to or following the termination of his or her service as a director.
8
Director Compensation Table
The table below summarizes the actual compensation paid by the Company to non-employee directors during the year ended December 31, 2014.
(a) | (b) | (c) | (d) | (e) | (f) | (g) | (h) | |||||||||||||||||||||
Name | Fees Earned in Cash ($) (1) |
Stock Awards ($) (1)(2)(4) |
Option Awards ($) (3)(4) |
Non-Equity ($) |
Change in Compensation Earnings ($) |
All Other Compensation ($) |
Total ($) |
|||||||||||||||||||||
Stuart M. Essig |
66,700 | 100,000 | 0 | | | | 166,700 | |||||||||||||||||||||
Richard E. Fogg (5) |
11,900 | 0 | 0 | | | | 11,900 | |||||||||||||||||||||
John W. Gerdelman |
78,900 | 100,000 | 0 | | | | 178,900 | |||||||||||||||||||||
Lemuel E. Lewis |
85,400 | 100,000 | 0 | | | | 185,400 | |||||||||||||||||||||
Martha H. Marsh |
82,000 | 100,000 | 0 | | | | 182,000 | |||||||||||||||||||||
Eddie N. Moore, Jr. |
75,400 | 100,000 | 0 | | | | 175,400 | |||||||||||||||||||||
James E. Rogers |
67,700 | 100,000 | 0 | | | | 167,700 | |||||||||||||||||||||
David S. Simmons |
68,500 | 100,000 | 0 | | | | 168,500 | |||||||||||||||||||||
Robert C. Sledd |
80,700 | 100,000 | 0 | | | | 180,700 | |||||||||||||||||||||
Anne Marie Whittemore |
100,600 | 100,000 | 0 | | | | 200,600 |
(1) Includes amounts deferred by the directors under the Directors Deferred Compensation Plan.
(2) The amounts included in the Stock Awards column are the aggregate grant date fair value of the awards computed in accordance with the FASB ASC Topic 718.
(3) Option Awards were not granted to Directors in 2014.
(4) As of December 31, 2014, each director had the following number of stock awards and option awards outstanding:
Stock Awards | Option Awards | |||||||
Mr. Essig |
3,014 | | ||||||
Mr. Fogg |
0 | | ||||||
Mr. Gerdelman |
3,014 | | ||||||
Mr. Lewis |
3,014 | | ||||||
Ms Marsh |
3,014 | | ||||||
Mr. Moore |
3,014 | | ||||||
Mr. Rogers |
3,014 | 15,000 | ||||||
Mr. Simmons |
3,014 | | ||||||
Mr. Sledd |
3,014 | | ||||||
Ms. Whittemore |
3,014 | |
(5) Mr. Fogg retired from the Board of Directors at the 2014 Annual Meeting.
9
Stock Ownership Guidelines for Directors
The Company maintains stock ownership guidelines for its directors which provide that each director shall attain, within five years after his or her service on the Board begins, a level of equity ownership of Common Stock having a value of at least five times the annual cash retainer fee or $150,000, whichever is higher. Each director who has served on the Board for at least five years has achieved this ownership objective.
Director Candidate Recommendations and Nominations by Shareholders. The Governance & Nominating Committee charter provides that the Governance & Nominating Committee will consider director candidate recommendations by shareholders. Shareholders should submit any such recommendations to the Governance & Nominating Committee through the method described under Communications with the Board of Directors below. In addition, our Bylaws provide that any shareholder of record entitled to vote for the election of directors at the applicable meeting of shareholders may nominate directors by complying with the notice procedures set forth in the Bylaws and summarized in Shareholder Proposals on page 59 of this proxy statement.
Process for Identifying and Evaluating Director Candidates. The Governance & Nominating Committee evaluates all director candidates in accordance with the director qualification standards and the criteria described in our Corporate Governance Guidelines. These guidelines require the Governance & Nominating Committee on an annual basis to review and evaluate the requisite skills and characteristics of individual Board members and nominees as well as the composition of the Board as a whole. This assessment includes whether the member or candidate is independent and includes considerations of diversity, age, skills and experience in the context of the Boards needs. The goal of the Governance & Nominating Committee is to have a Board whose membership reflects a mix of diverse skill sets, technical expertise, educational and professional backgrounds, industry experiences and public service as well as perspectives of different genders and ethnicities. The Governance & Nominating Committee reviews its annual assessment with the Board each year and, as new member candidates are sought, attempts to maintain and enhance the level of diverse backgrounds and viewpoints of directors constituting the Board. As part of the Boards annual self-assessment process, the Board will consider the effectiveness of its overall composition and structure as well as its performance and functioning.
Our Bylaws provide that no director nominee can stand for election if, at the time of appointment or election, the nominee is over the age of 72. There are no differences in the manner in which the Governance & Nominating Committee evaluates director candidates based on whether the candidate is recommended by a shareholder. The Governance & Nominating Committee did not receive any nominations from any shareholders for the 2015 Annual Meeting.
COMMUNICATIONS WITH THE BOARD OF DIRECTORS
The Board of Directors has approved a process for shareholders and other interested parties to send communications to the Board. Shareholders and other interested parties can send written communications to the Board, any committee of the Board, non-management directors as a group, the lead director or any other individual director at the following address: P.O. Box 26383, Richmond, Virginia 23260. All communications will be relayed directly to the applicable director(s).
10
PROPOSAL 1: ELECTION OF DIRECTORS
Eleven directors are nominated for election to the Board of Directors for a one-year term expiring at the 2016 Annual Meeting of Shareholders or until their respective successors are elected. Each nominee has agreed to serve if elected and qualified. If any nominee is not able to serve, the Board may designate a substitute or reduce the number of directors serving on the Board. Proxies will be voted for the nominees shown below (or if not able to serve, such substitutes as may be designated by the Board). The Board has no reason to believe that any of the nominees will be unable to serve.
Our Bylaws currently provide that the Board of Directors shall consist of eleven directors. The Governance & Nominating Committee has recommended to the Board of Directors, and the Board of Directors has approved, eleven persons as nominees for election to the Board of Directors. Proxies cannot be voted for a greater number of directors than the number of nominees named.
Information on each nominee, including the particular experience, qualifications, attributes or skills that led the Board to conclude that he or she should serve as a director of the Company, is set forth below.
|
James L. Bierman, 62, has served as President and Chief Executive Officer of Owens & Minor since September 2014. He served as President and Chief Operating Officer from 2013 to 2014 and as Executive Vice President and Chief Operating Officer from 2012 to 2013. From 2007 to 2012, he served as the Companys Chief Financial Officer. He previously held senior positions at Quintiles Transnational and was a 22-year veteran of Arthur Andersen where he was a partner for 10 years. Mr. Bierman currently serves on the board of directors of TeamHealth Holdings, Inc. where he is chairman of the boards audit and governance and nominating committees. Mr. Bierman was appointed as a director of the Company in September 2014.
The Board of Directors has nominated Mr. Bierman to serve as a director of the Company based on his position as Chief Executive Officer and his unique ability to communicate to and inform the Board about the Companys day-to-day operations and management issues as well as industry developments. The Board believes that Mr. Bierman brings an invaluable perspective on the Companys historical and current operations and its ongoing relationships with customers and suppliers. |
11
|
Stuart M. Essig, 53, has served as Chairman of the Board of Integra LifeSciences Holdings Corporation since 2012. From 1997 to 2012, he served as Chief Executive Officer of Integra LifeSciences, during which time he transitioned the business into a global surgical products company. Prior to joining Integra LifeSciences, Mr. Essig was a managing director in mergers and acquisitions for Goldman Sachs Group, Inc. He also has been a Managing Partner since 2012 of Prettybrook Partners, a healthcare advisory firm, and a Venture Partner since 2013 in Wellington Partners, a pan-European venture capital firm. In addition to Integra LifeSciences, he also currently serves on the boards of directors of St. Jude Medical, Inc. and Breg, Inc. Mr. Essig has been a director of the Company since 2013.
The Board of Directors has nominated Mr. Essig to continue his service as a director of the Company based on his strong background and leadership experience in the medical device manufacturing industry and broad-based knowledge of the health care industry. His insights into the medical supplies manufacturing industry, both domestic and international, bring a unique perspective to Owens & Minors board that assists us both logistically and strategically as we seek to manage and grow our many relationships with the manufacturing community at home and abroad. | |
|
John W. Gerdelman, 62, is Managing Partner of River2, an investment and consulting partnership. Mr. Gerdelman was President of Long Lines Limited, a telecommunications service provider, from 2010 to 2011. Before joining Long Lines in 2010, he co-founded Intelliden Corporation, a network solutions provider for which Mr. Gerdelman served as Executive Chairman from 2003 until it was acquired by IBM in 2010. Mr. Gerdelman has served in a number of leadership positions for other telecommunications companies, including 15 years with MCI Communications Corporation. He currently serves on the board of directors of Brocade Communications Systems, Inc. and previously served on the boards of Sycamore Networks, Inc., Proxim Wireless Corporation, APAC Customer Services, Inc. and McData Corporation. Mr. Gerdelman has been a director of the Company since 2010.
The Board of Directors has nominated Mr. Gerdelman to continue his service as a director of the Company based on his unique entrepreneurial background, extensive experience in finance and accounting and expertise in telecommunications and information systems. The Board believes the Company will benefit from Mr. Gerdelmans business management experience and perspectives as Owens & Minor continues to expand systems and technology solutions used to support our own business operations as well as to provide customers with new products for supply chain management. |
12
|
Lemuel E. Lewis, 68, is President of LocalWeather.com, a web-based privately-held media company he founded in 2008. He served as Executive Vice President and Chief Financial Officer of Landmark Communications, Inc., a privately-held media and broadcasting company, from 2000 to 2006. Mr. Lewis was appointed to the Board of the Federal Reserve Bank in 2004 and served as Deputy Chairman from 2007 to 2008, Chairman of the Audit Committee from 2005 to 2008, and Chairman from 2009 until his retirement from the board on December 31, 2010. He currently serves on the board of directors of Markel Corporation, where he is Chairman of the Audit Committee. He also serves on the board of directors of Dollar Tree, Inc. and previously served on the board of Landmark Communications, Inc. Mr. Lewis has been a director of the Company since 2011.
The Board of Directors has nominated Mr. Lewis to continue his service as a director of the Company based on his breadth of experience in accounting and finance through his service as Chief Financial Officer of a private media company, as well as his service on the Board of the Federal Reserve Bank of Richmond where he chaired the Audit Committee. He also brings a wide range of differing perspectives to the Company based on his service on a number of Virginia college and foundation boards and through his membership on the boards of two other public companies, including service on their audit committees. | |
|
Martha H. Marsh, 66, retired in 2010 as President & Chief Executive Officer of Stanford Hospital & Clinics, a position she held since 2002. She also served as the Chief Executive Officer of the University of California Davis Health System from 1999 to 2002. After beginning her career at Arthur Andersen in 1975, she served the health care industry for more than thirty years in a variety of leadership positions, including as Senior Vice President for Professional Services and Managed Care at the University of Pennsylvania Health System. Ms. Marsh has also served on a variety of health care boards and committees. She currently serves on the boards of directors of AMN Healthcare Services, Inc. and Thoratec Corporation. Ms. Marsh has been a director of the Company since 2012.
The Board of Directors has nominated Ms. Marsh to continue her service as a director of the Company based on her extensive background in and knowledge of the health care industry and specifically the health care provider marketplace with which we conduct our business. Having served in the lead management position of some of the most prestigious health care systems in the United States, she brings unique perspectives on the requirements of and challenges faced by the health care provider industry as well as a deep understanding of the entire U.S. health care marketplace. Her broad-based background in accounting, finance, operations and management in the context of the health care industry brings a multi-disciplinary and highly relevant point of view to our Board of Directors in assessing issues and challenges within the health care marketplace. |
13
|
Eddie N. Moore, Jr., 67, currently serves as Interim President and Chief Executive Officer of Norfolk State University. From 2011 to 2012, he served as President of St. Pauls College. He is President Emeritus of Virginia State University after serving as its President from 1993 to 2010. Prior to leading Virginia State University, Mr. Moore served as state treasurer for the Commonwealth of Virginia, heading the Department of the Treasury and serving on fifteen state boards and authorities. He also serves on the board of directors of Universal Corporation. Mr. Moore has been a director of the Company since 2005.
The Board of Directors has nominated Mr. Moore to continue his service as a director of the Company based on his strong background in accounting and finance, which qualify him to serve as an audit committee financial expert, and his leadership experience in managing prominent educational institutions. The Board believes that Mr. Moores experiences in the public sector bring unique perspectives and disciplines to the Boards deliberations and decision-making processes. | |
|
James E. Rogers, 69, has served as Chairman of the Board of BackOffice Associates, LLC, a private company that provides data quality, migration and governance solutions, since 2011. He served as President of SCI Investors Inc, a private equity investment firm, from 1993 until his retirement in 2011. He also serves on the board of directors of NewMarket Corporation and formerly served on the boards of Caraustar Industries, Inc., Wellman, Inc., Chesapeake Corp. and Cadmus Communications, Inc. Mr. Rogers has been a director of the Company since 1991.
The Board of Directors has nominated Mr. Rogers to continue his service as a director of the Company based on his leadership experience as a former chief executive officer and other senior executive positions with several public and private companies, as well as his breadth of knowledge about the Company, its culture and the health care distribution industry acquired through his 24-year tenure on the Companys Board of Directors. In addition, Mr. Rogers has demonstrated significant leadership and communication skills in his service as the Companys independent lead director for more than ten years until 2014. | |
|
David S. Simmons, 50, has served as Chairman & Chief Executive Officer of Pharmaceutical Product Development, LLC, a global contract pharmaceutical research organization, since 2012. From 2001 to 2012, Mr. Simmons served in a variety of management positions with Pfizer, Inc., including as President and General Manager of the Emerging Markets and Established Products Business Units, Regional President of the Eastern Europe Pharmaceutical Division, President of the Pharmaceutical Division in Greece and Vice President of Marketing in Canada. Mr. Simmons has been a director of the Company since 2013.
The Board of Directors has nominated Mr. Simmons to continue his service as a director of the Company based on his extensive background and experience in the global pharmaceutical business and the breadth of knowledge he brings to Owens & Minor and its international operations through his leadership positions with Pfizer in Europe and abroad. With a strong background in finance, operations and logistics in the context of the pharmaceutical industry, Mr. Simmons brings unique knowledge and perspectives to the Company, especially with respect to our third party logistics growth and globalization strategy. |
14
|
Robert C. Sledd, 62, served as a Senior Economic Advisor to the Governor of Virginia from 2010 to 2014. Since 2008, he also has served as Managing Partner of Pinnacle Ventures, LLC and Sledd Properties, LLC. From 1995 to 2008, he served as Chairman of Performance Food Group Co. (PFG), a foodservice distribution company that he co-founded in 1987. He served as Chief Executive Officer of PFG from 1987 to 2001 and from 2004 to 2006. He also serves on the boards of directors of SCP Pool Corporation and Universal Corporation. Mr. Sledd has been a director of the Company since 2007.
The Board of Directors has nominated Mr. Sledd to continue his service as a director of the Company based on his expertise in economic and business development policy, as well as his experience as a former chief executive of a foodservice distribution company, including his knowledge and understanding of the specific issues and challenges faced by companies in the business of distribution and supply chain management. His experiences in founding, growing and taking public PFG allow him to contribute to the Board a breadth of perspectives and ideas on matters of corporate management, governance and strategic growth. | |
|
Craig R. Smith, 63, has served as Chairman of the Board of Owens & Minor since 2013 and as Executive Chairman since September 2014. He served as Chairman & Chief Executive Officer of the Company from 2013 until September 2014 and as President & Chief Executive Officer from 2005 until 2013. Mr. Smith, who joined the Company in 1989, served as President & Chief Operating Officer from 1999 until 2005 and as Chief Operating Officer from 1995 to 1999. He also serves on the board of directors of the Virginia Biotechnology Research Partnership Authority. Mr. Smith has been a director of the Company since 2005.
The Board of Directors has nominated Mr. Smith to continue his service as a director of the Company based on the depth of his experience in leading and managing Owens & Minors growth and operations over the past two decades and navigating the constantly changing healthcare marketplace. The Board believes that Mr. Smiths extensive knowledge of the Company, deep understanding of the healthcare supply logistics industry, strong relationships with the Companys customers and suppliers and success in leading the Companys growth uniquely qualify him to serve as the Boards Chairman. | |
|
Anne Marie Whittemore, 68, has been a partner in the law firm of McGuireWoods LLP since 1977. She also serves on the board of directors of T. Rowe Price Group, Inc., formerly served on the board of Albemarle Corporation and is a former chairman of the board of the Federal Reserve Bank of Richmond, Virginia. Ms. Whittemore has been a director of the Company since 1991 and lead director since 2014.
The Board of Directors has nominated Ms. Whittemore to continue her service as a director of the Company based on the unique background and perspectives she brings to the board as an attorney whose areas of specialty include corporate governance and complex commercial and securities litigation matters. Her experience includes representation of several Fortune 100 corporations and other companies in matters involving corporate governance and shareholder matters. Ms. Whittemore also has extensive experience as a public company director and member of both compensation and governance committees, which the Board believes contributes to her strong leadership skills and led to her appointment in 2014 as lead director. |
The Board of Directors recommends a vote FOR the election of each nominee as director.
15
PROPOSAL 2: APPROVAL OF THE PROPOSED OWENS & MINOR, INC. 2015 STOCK INCENTIVE PLAN
The Company currently has in effect the 2005 Stock Incentive Plan (the 2005 Plan). The 2005 Plan permits the grant of options, stock appreciation rights, stock awards, performance shares (sometimes called stock units) and incentive awards. The 2005 Plan was first adopted by the Board of Directors in 2005 and was approved by shareholders in 2005 and 2010.
On February 5, 2015, the Board adopted the 2015 Stock Incentive Plan (the 2015 Plan), subject to the approval of shareholders. Like the 2005 Plan, the 2015 Plan authorizes the grant of options, stock appreciation rights, stock awards, stock units and incentive awards. If the shareholders approve the 2015 Plan, no additional awards will be granted under the 2005 Plan.
The Board believes that the 2005 Plan has benefited, and the 2015 Plan will benefit, the Company, by (i) assisting in recruiting and retaining the services of individuals with high ability and initiative, (ii) providing greater incentives for employees and other individuals who provide valuable services to the Company and its subsidiaries and affiliates and (iii) associating the interests of those persons with those of the Company and its shareholders. The more significant features of the 2015 Plan are summarized below.
The following summary of the material features of the 2015 Plan is qualified in its entirety by reference to the terms of the 2015 Plan, a copy of which is attached as Appendix A to this proxy statement and to the electronic copy of this proxy statement filed with the SEC and may be accessed from the SECs website at www.sec.gov.
Administration of the 2015 Plan
The 2015 Plan is administered by the Compensation & Benefits Committee of the Board (sometimes referred to in this summary as the Committee). The Committee approves all terms of awards under the 2015 Plan. The Committee also approves who will receive grants under the 2015 Plan, determines the type of award that will be granted and approves the number of shares of Common Stock subject to the grant.
However, the Governance & Nominating Committee of the Board administers the 2015 Plan in the case of any award that is made to a member of the Board who is not also an employee of the Company or an affiliate. References in this summary to the Committee include the Compensation & Benefits Committee and, with respect to awards made to non-employee directors, the Governance & Nominating Committee.
Because awards under the 2015 Plan are made at the Committees discretion, we are unable to determine who will be selected to receive awards or the type, size or terms of the awards that may be granted. For the same reason, we are unable to determine the awards that would have been granted last year if the 2015 Plan had been in effect. However, outstanding awards previously granted under the 2005 Plan are reported herein. See Grants of Plan Based Awards Table on page 48 and Outstanding Equity Awards at Fiscal Year-End Table on page 50 of this proxy statement.
Eligibility
All of our employees and employees of our subsidiaries and affiliates, are eligible to receive grants under the 2015 Plan. In addition, members of the Board and individuals who provide services to us or a subsidiary or affiliate may receive grants under the 2015 Plan.
Share Authorization
The maximum aggregate number of shares of Common Stock that may be issued under the 2015 Plan is 3,000,000 shares. In connection with stock splits, stock dividends, recapitalizations and certain other events, the Board will make adjustments that it deems appropriate in the aggregate number of shares of Common Stock that
16
may be issued under the 2015 Plan, the terms of outstanding awards and the per individual grant limitations (described below under Section 162(m)). In determining the number of shares to include in the 2015 Plan, the Committee considered anticipated share usage over the next three to five years and likely institutional investor perceptions of the additional share request. The Committee also considered annual share burn rate and overhang relative to its Peer Companies (set forth on page 32 of this proxy statement) and peers in other industry groups. The Companys burn rate is below competitive median, and the requested share authorization will position the Companys total overhang below the median of its peers. The Committee believes this share request will be sufficient to provide competitive equity grants to our employees over the next few years and will not be perceived by most shareholders as overly dilutive.
If any options or stock appreciation rights terminate, expire or are canceled, forfeited, exchanged or surrendered without having been exercised or paid or if any stock awards or stock unit awards are forfeited, the Common Stock subject to such awards, to the extent of the termination, expiration, cancellation, forfeiture, surrender or cash settlement, will again be available for awards under the 2015 Plan. Any shares of Common Stock that are tendered or withheld from the settlement of an award to satisfy the grant or exercise price or to satisfy a tax withholding obligation under an award will not be available for future awards granted under the 2015 Plan. If Common Stock is issued in settlement of a stock appreciation right, the number of shares available for future awards will be reduced by the number of shares for which the stock appreciation right was exercised rather than the number of shares issued.
Awards
The Committee will determine the eligible individuals who will receive awards under the 2015 Plan and the Committee will specify the type of award that is made and will prescribe the terms and conditions that govern each award. The 2015 Plan generally provides that no award will be fully exercisable or entirely vested before the third anniversary of the grant or before the first anniversary of the grant if the award is made to a member of the Board who is not an employee of the Company or a subsidiary or if the award will become exercisable or vest on account of achieving one or more performance objectives. Notwithstanding the preceding sentence, the Committee may accelerate the exercisability or vesting of awards (a) in connection with a termination of employment or service or (b) if the award has been outstanding for at least one year. The Committee also may accelerate the exercisability or vesting of awards with respect to up to 300,000 shares of Common Stock without regard to the requirements of the preceding sentence.
Options. The 2015 Plan authorizes the Committee to grant incentive stock options (under Section 421 of the Internal Revenue Code) and options that do not qualify as incentive stock options. The exercise price of each option will be determined by the Committee, provided that the price cannot be less than 100% of the fair market value of the Common Stock on the date on which the option is granted (or 110% of the shares fair market value on the grant date in the case of an incentive stock option to an individual who is a ten percent shareholder under Sections 422 and 424 of the Code). Except in the event of stock splits, stock dividends and other changes in our capitalization, unless approved by shareholders, the exercise price of an outstanding option cannot be reduced and no payment can be made to cancel an option if the exercise price exceeds the shares fair market value on the date of cancellation.
The exercise price for any option is generally payable (i) in cash, (ii) in a cash equivalent acceptable to the Committee, or (iii) by the surrender of Common Stock (or attestation of ownership of Common Stock) with an aggregate fair market value on the date on which the option is exercised equal to the exercise price for the number of shares being purchased.
The term of an option cannot exceed ten years from the date of grant (or five years in the case of an incentive share option granted to a ten percent shareholder). The Committee may grant options that have a term less than the maximum term permitted under the 2015 Plan. The 2015 Plan provides for the automatic exercise of options if (a) the participant remains in the continuous employ or service of the Company from the date of grant
17
until the stated expiration date of the option and (b) the fair market value of the shares subject to the option exceeds the exercise price. In that event, if not exercised by the participant, the option will be exercised on the stated expiration date and the participant will be issued shares of Common Stock that have a fair market value equal to the excess of the aggregate number of shares subject to the option over the aggregate exercise price of the option.
Stock Awards. The 2015 Plan also provides for the grant of stock awards. A stock award is an award of Common Stock that will be subject to restrictions on transferability and other restrictions as the Committee determines on the date of grant and consistent with the terms of the 2015 Plan, including the vesting requirements described above. The vesting requirements or restrictions may be stated with reference to one or more performance objectives, including objectives stated with respect to performance goals as described below under Section 162(m). The restrictions, if any, may lapse over a specified period of time or through the satisfaction of conditions, in installments or otherwise, as the Committee may determine.
A participant who receives a stock award will have all of the rights of a shareholder as to those shares, including, without limitation, the right to vote and the right to receive dividends or distributions on the shares; provided, however, that the 2015 Plan provides that dividends payable on a stock award that does not vest solely on account of continued employment or service will be payable when, and only to the extent that, the underlying stock award vests. During the period, if any, when stock awards are non-transferable or forfeitable, (i) a participant is prohibited from selling, transferring, pledging, exchanging, hypothecating or otherwise disposing of his or her stock award shares, (ii) the company will retain custody of the certificates and (iii) a participant must deliver a share power to the company for each stock award.
Stock Appreciation Rights. The 2015 Plan authorizes the Committee to grant stock appreciation rights that provide the recipient with the right to receive, upon exercise of the stock appreciation right, cash, Common Stock or a combination of the two. The amount that the recipient will receive upon exercise of the stock appreciation right generally will equal the excess of the fair market value of the Common Stock on the date of exercise over the shares fair market value on the date of grant (the initial value). Stock appreciation rights will become exercisable in accordance with terms prescribed by the Committee and consistent with the terms of the 2015 Plan, including the vesting requirements described above. Stock appreciation rights may be granted in tandem with an option grant or independently from an option grant. The term of a stock appreciation right cannot exceed ten years from the date of grant or five years in the case of a share appreciation right granted in tandem with an incentive stock option awarded to a ten percent shareholder. The Committee may grant stock appreciation rights that have a term less than the maximum terms permitted under the 2015 Plan. The 2015 Plan provides for the automatic exercise of a stock appreciation right if (a) the participant remains in the continuous employ or service from the date of grant until the stated expiration date of the stock appreciation right and (b) the fair market value of the shares subject to the stock appreciation right exceeds the initial value per share. In that event, if not exercised by the participant, the stock appreciation right will be exercised on the stated expiration date and the participant will receive the amount payable for exercises on that date.
Except in the case of stock splits, stock dividends and other changes in our capitalization, the initial value of an outstanding stock appreciation right cannot be reduced without the approval of shareholders. In addition, the 2015 Plan provides that no payment may be made on account of the cancellation of a stock appreciation right if the initial value exceeds the fair market value of a share of Common Stock.
Stock Units. The 2015 Plan also authorizes the Committee to grant awards of stock units. Stock units represent the participants right to receive an amount, based on the value of the Common Stock, if the requirements established by the Committee are satisfied. Consistent with the terms of the 2015 Plan, including the vesting requirements described above, the Committee will determine the applicable performance period, the performance goals and such other conditions that apply to the stock unit award. Performance goals may be stated with respect to the performance criteria described below under Section 162(m) or such other criteria determined by the Committee. If the performance goals and other requirements are met, stock units will be paid in cash, Common Stock or a combination thereof.
18
The Committee may grant dividend equivalents in connection with the grant of stock units. Dividend equivalents may be paid currently or accrued as contingent obligations (in which case they may be deemed to have been invested in shares of Common Stock) and may be payable in cash, Common Stock or a combination of the two. The Committee will determine the terms of any dividend equivalents. However, the 2015 Plan provides that amounts payable under dividend equivalent rights that relate to a stock unit award that does not vest solely on account of continued employment or service will be payable when, and only to the extent that, the underlying award vests.
Incentive Awards. The 2015 Plan also permits the grant of incentive awards. An incentive award is an opportunity to earn a payment upon the terms and conditions prescribed by the Committee. The terms and conditions may provide that the incentive award will be earned only if the participants employment continues for a specified period or only to the extent that the participant, the Company or an affiliate achieves objectives measured over a period of at least one year. The objectives may be stated with reference to one or more of the performance criteria described below under Section 162(m) or such other criteria determined by the Committee. If an incentive award is earned, the amount payable will be paid in cash, Common Stock or a combination thereof.
Change in Control
If we experience a change in control, the Committee may, at its discretion, provide that all outstanding options, stock appreciation rights, stock awards, stock unit awards and incentive awards will be assumed by the surviving entity, or will be replaced by a comparable substitute award of substantially equal value granted by the surviving entity. If an award is not assumed or replaced with a substitute award, the Committee may provide that (i) all outstanding options and stock appreciation rights will be fully exercisable on the change in control, (ii) restrictions and conditions on outstanding stock awards will lapse upon the change in control, (iii) stock units will become earned in their entirety and (iv) incentive awards will be earned, in whole or in part, in accordance with their terms. If an award is not assumed or replaced with a substitute award, the Committee may also provide that participants must surrender their outstanding options, stock appreciation rights, stock awards, stock unit awards, and incentive awards in exchange for a payment, in cash or our Common Stock or other securities or consideration received by shareholders in the change in control transaction, equal to the value received by shareholders in the change in control transaction (or, in the case of options and stock appreciation rights, the amount by which that transaction value exceeds the exercise price or initial value).
In summary, a change of control under the 2015 Plan occurs if:
| a person, entity or affiliated group (with certain exceptions) acquires, in a transaction or series of transactions, at least 30% of our combined voting power; |
| we merge into another entity unless the voting securities of the Company immediately prior to the merger continue to represent more than 50% of the combined voting power of the securities in the merged entity or its parent; |
| the stockholders approve a plan of complete liquidation or an agreement for the sale or disposition of all or substantially all of our assets; or |
| during any period of two consecutive years individuals who, at the beginning of such period, constitute our Board, together with any new directors whose nomination or election was approved by a majority of the directors then so in office (other than individuals who become directors in connection with certain transactions or election contests) cease for any reason to constitute a majority of our Board. |
The Internal Revenue Code has special rules that apply to parachute payments, i.e., compensation that is payable on account of a change in control. If the parachute payments exceed a safe harbor amount prescribed by the Internal Revenue Code, then the recipient is liable for a 20% excise tax on a portion of the parachute payments, and the Company is not allowed to claim a federal income tax deduction for a portion of the parachute payments.
19
The 2015 Plan provides for a reduction in benefits if the benefits of awards, either alone or together with parachute payments under other plans and agreements, exceed the safe harbor amount. In that event, the participants total parachute payments will be reduced to the safe harbor amount, i.e., the maximum amount that may be paid without an excise tax liability or loss of deduction. However, the benefits will not be reduced, and the participant will receive all of the parachute payments, if the participant will receive a greater after-tax benefit, taking into account the excise tax payable by the participant, by receiving all of the parachute payments. The 2015 Plan provides that these provisions do not apply to a participant who, under an agreement with the Company or the terms of another plan is not permitted to receive parachute payments in excess of the safe harbor amount.
Section 162(m)
Section 162(m) of the Internal Revenue Code limits, to $1,000,000, the deduction that a public corporation may claim for compensation paid to each of its chief executive officer and its three other most highly paid executive officers (other than the chief financial officer). The deduction limitation does not apply to compensation that qualifies as performance based compensation under Section 162(m).
Awards granted under the 2015 Plan can qualify as performance based compensation under Section 162(m) only if, among other things, the plan, as approved by shareholders (i) includes a limit on the benefits that an individual may receive in a stated period and (ii) the plan identifies the performance measures or criteria that may be used for awards that are intended to qualify as performance based compensation.
As required by Section 162(m), the 2015 Plan includes limits on the benefits that any participant may receive in a stated period. The 2015 Plan provides that no participant may be granted, in any calendar year (i) options and stock appreciation rights covering more than 2,000,000 shares of Common Stock, (ii) stock awards and stock unit awards covering more than 500,000 shares of Common Stock or (iii) incentive awards exceeding $5,000,000. Each of these limits will be doubled with respect to awards granted to a Participant during the calendar year in which the Participant first commences employment. The two preceding sentences do not apply to a non-employee director, i.e., member of the Board who is not an employee. In any calendar year a non-employee director may not be granted (i) options or stock appreciation rights covering more than 60,000 shares of Common Stock or (ii) stock awards and stock unit awards covering more than 20,000 shares of Common Stock.
The 2015 Plan also identifies performance criteria that may be used to establish performance goals that will determine whether an award becomes vested or is earned. The Committee may prescribe that an award will become vested or be earned only upon the attainment of performance goals or objectives stated with respect to one or more of: (i) gross, operating or net earnings before or after taxes; (ii) return on equity; (iii) return on capital; (iv) return on sales; (v) return on assets or net assets; (vi) earnings per share; (vii) cash flow per share; (viii) book value per share; (ix) earnings growth; (x) sales or sales growth; (xi) volume growth; (xii) cash flow (as defined by the Committee); (xiii) Fair Market Value; (xiv) total shareholder return; (xv) market share; (xvi) productivity; (xvii) level of expenses; (xviii) quality; (xix) safety; (xx) customer satisfaction; (xxi) total economic value added; (xxii) earnings before interest, taxes, depreciation and amortization and (xxiii) revenues or revenue growth.
A performance goal or objective may be stated with respect to the Company, a subsidiary or a business unit and also may be stated with respect to one or more of these criteria or may be expressed on an absolute basis or relative to the performance of one or more similarly situated companies or a published index. In establishing a performance goal or objective, the Committee may exclude any or all special, unusual or extraordinary items as determined under generally accepted accounting principles, including the charges or costs associated with restructurings of the Company, discontinued operations, other unusual or non-recurring items and the cumulative effects of accounting changes. To the extent allowed by Section 162(m), the Committee may also adjust performance goals or objectives to reflect the impact of unusual or non-recurring events affecting the Company and for changes in applicable tax laws and accounting principles.
20
Return of Awards; Repayment
The 2015 Plan provides that all awards, and all payments under awards, are subject to any policy that the Company adopts requiring the return or repayment of benefits, i.e., a claw-back policy. To the extent required by any such policy, as in effect on the date that the award is granted, the date the option or stock appreciation right was exercised, the date of payment or the date the award became vested, a participant will be required to return any award (if not previously exercised or settled) and any payment previously made with respect to an award (if the award has vested or been settled).
Amendment; Termination
The 2015 Plan may be amended or terminated at any time by the Board; provided that no amendment may adversely impair the benefits of participants under outstanding awards. Our shareholders must approve any amendment if such approval is required under applicable law or stock exchange requirements. Our shareholders also must approve any amendment that materially increases the benefits accruing to participants under the 2015 Plan, materially increases the aggregate number of shares of Common Stock that may be issued under the 2015 Plan (other than adjustments to reflect stock dividends, stock splits and other changes in capitalization) or materially modifies the requirements as to eligibility for participation in the 2015 Plan. In addition, except in connection with adjustments to reflect stock dividends, stock splits and other changes in capitalization, the exercise price of an option or the initial value of a stock appreciation right may not be reduced and no action that would constitute a re-pricing of such awards may be taken without the approval of shareholders.
The 2015 Plan provides that, unless terminated sooner by the Board or extended with shareholder approval, no awards may be made under the 2015 Plan after April 29, 2025 and no incentive stock options may be granted after February 4, 2025.
Federal Tax Consequences
Counsel advised us regarding the federal income tax consequences of the 2015 Plan. No income is recognized by a participant at the time an option or stock appreciation rights is granted. If the option is an incentive stock option, no income will be recognized upon the participants exercise of the incentive stock option. Income is recognized by a participant when he or she disposes of shares acquired under an incentive stock option. The exercise of a nonqualified stock option or a stock appreciation right generally is a taxable event that requires the participant to recognize, as ordinary income, the difference between the shares fair market value and the option price or the amount paid in settlement of the stock appreciation right.
Income is recognized on account of the grant of a stock award when the shares subject to the award first become transferable or are no longer subject to a substantial risk of forfeiture. At that time the participant recognizes ordinary income equal to the fair market value of the Common Stock, less any amount paid by the participant for the Common Stock.
No income is recognized upon the grant of stock units or incentive awards. Income will be recognized on the date that payment is made under the stock unit award or incentive award in an amount paid in settlement of the stock units or incentive award.
The employer (either the Company or its affiliate) generally will be entitled to claim a federal income tax deduction on account of the exercise of a nonqualified stock option or stock appreciation right, the vesting of a stock award or the settlement of stock units and incentive awards. The amount of the deduction generally is equal to the ordinary income recognized by the participant. The employer will not be entitled to a federal income tax deduction on account of the grant or exercise of an incentive stock option but may claim a federal income tax deduction on account of certain dispositions of shares acquired under an incentive stock option.
The Board of Directors recommends that you vote FOR approval of the proposed Owens & Minor, Inc. 2015 Stock Incentive Plan.
21
PROPOSAL 3: RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Audit Committee (with confirmation of the Board) has selected KPMG LLP to serve as the Companys independent registered public accounting firm for the year ending December 31, 2015 and has directed that management submit such appointment of KPMG LLP for ratification by the shareholders at the annual meeting. Representatives of KPMG LLP will be present at the annual meeting to answer questions and to make a statement, if they desire to do so.
Under the Sarbanes-Oxley Act of 2002 and the rules of the SEC promulgated thereunder, the Audit Committee is solely responsible for the appointment, compensation and oversight of the work of the Companys independent registered public accounting firm. Shareholder ratification of this appointment is not required by the Companys Bylaws or otherwise. If shareholders fail to ratify the appointment, the Audit Committee will take such failure into consideration in future years. If shareholders ratify the appointment, the Audit Committee, in its discretion, may direct the appointment of a different independent registered public accounting firm at any time during the year if it is determined that such a change would be in the best interests of the Company.
The Board of Directors recommends a vote FOR the ratification of the appointment of KPMG LLP to serve as the Companys independent registered public accounting firm for 2015.
FEES PAID TO INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
For each of the years ended December 31, 2014 and 2013, KPMG LLP billed the Company the fees set forth below in connection with professional services rendered by that firm to the Company:
Year 2014 | Year 2013* | |||||||
Audit Fees |
$ | 1,779,500 | $ | 1,605,000 | ||||
Audit-Related Fees |
693,310 | 144,750 | ||||||
Tax Fees |
390,972 | 0 | ||||||
All Other Fees |
0 | 31,750 | ||||||
|
|
|
|
|||||
Total |
$ | 2,863,782 | $ | 1,781,500 |
* For 2013, $120,250 that was originally included under All Other Fees has been reclassified to Audit-Related Fees.
Audit Fees. These were fees for professional services performed for the audit of the Companys annual financial statements and review of financial statements included in the Companys filings on Forms 10-K and 10-Q, Sarbanes-Oxley compliance, services normally provided in connection with statutory and regulatory filings or engagements and provision of a comfort letter in connection with our 2014 debt offering.
Tax Fees. These were fees primarily for advice and consulting services related to the structuring of international operations, the restructuring of business operations and the structuring of and performance of tax due diligence for a 2014 international acquisition.
Audit-Related Fees. These were fees primarily for the annual audits of the Companys employee benefit plan financial statements, internal control attestations in certain foreign jurisdictions, consultations by management related to financial accounting and reporting matters and assistance with financial due diligence in connection with acquisitions by the Company in 2014.
All Other Fees. These were fees for other non-audit related services, including accounting and advisory support services.
The Audit Committee has established policies and procedures for the approval and pre-approval of audit services and permitted non-audit services. The Audit Committee has the sole responsibility to engage and terminate the engagement of the Companys independent registered public accounting firm, to pre-approve such
22
firms performance of audit services and permitted non-audit services and to review with the Companys independent registered public accounting firm its fees and plans for all auditing services. All services provided by and fees paid to KPMG LLP in 2014 were pre-approved by the Audit Committee, and there were no instances of waiver of approval requirements or guidelines during this period. The Audit Committees pre-approval policies and procedures for services by independent registered public accounting firms are set forth in Appendix B to this proxy statement.
The Audit Committee is composed of four directors, each of whom is independent under the enhanced independence standards for audit committees in the Exchange Act and the rules thereunder as incorporated into the listing standards of the NYSE and under the Companys Corporate Governance Guidelines, and two of whom have been determined by the Board of Directors to be audit committee financial experts. The Audit Committee operates under a written charter adopted by the Board of Directors, which the Audit Committee reviews at least annually and revises as necessary to ensure compliance with current regulatory requirements and industry changes.
As its charter reflects, the Audit Committee has a broad array of duties and responsibilities. With respect to financial reporting and the financial reporting process, management, the Companys independent registered public accounting firm and the Audit Committee have the following respective responsibilities:
Management is responsible for:
| Establishing and maintaining the Companys internal control over financial reporting; |
| Assessing the effectiveness of the Companys internal control over financial reporting as of the end of each year; and |
| Preparation, presentation and integrity of the Companys consolidated financial statements. |
The Companys independent registered public accounting firm is responsible for:
| Performing an independent audit of the Companys consolidated financial statements and the Companys internal control over financial reporting; |
| Expressing an opinion as to the conformity of the Companys consolidated financial statements with U.S. generally accepted accounting principles; and |
| Expressing an opinion as to the effectiveness of the Companys internal control over financial reporting. |
The Audit Committee is responsible for:
| Selecting the Companys independent registered public accounting firm; |
| Overseeing and reviewing the financial statements and the accounting and financial reporting processes of the Company; and |
| Overseeing and reviewing managements evaluation of the effectiveness of internal control over financial reporting. |
In this context, the Audit Committee has met and held discussions with management and KPMG LLP, the Companys independent registered public accounting firm. Management represented to the Audit Committee that the Companys consolidated financial statements for the year ended December 31, 2014 were prepared in accordance with U.S. generally accepted accounting principles. The Audit Committee has reviewed and discussed these consolidated financial statements with management and KPMG LLP, including the scope of the independent registered public accounting firms responsibilities, critical accounting policies and practices used and significant financial reporting issues and judgments made in connection with the preparation of such financial statements.
23
The Audit Committee has discussed with KPMG LLP the matters required to be discussed by Statement on Auditing Standard No. 16, Communications with Audit Committees, issued by the Public Company Accounting Oversight Board (United States) (PCAOB). The Audit Committee has also received the written disclosures and the letter from KPMG LLP required by the PCAOB regarding the independence of that firm and has discussed with KPMG LLP the firms independence from the Company.
In addition, the Audit Committee has discussed with management its assessment of the effectiveness of internal control over financial reporting and has discussed with KPMG LLP its opinion as to the effectiveness of the Companys internal control over financial reporting.
Based upon its discussions with management and KPMG LLP and its review of the representations of management and the report of KPMG LLP to the Audit Committee, the Audit Committee recommended to the Board of Directors that the audited consolidated financial statements be included in the Companys Annual Report on Form 10-K for the year ended December 31, 2014 for filing with the SEC.
THE AUDIT COMMITTEE
Lemuel E. Lewis, Chairman
John W. Gerdelman
Eddie N. Moore, Jr.
David S. Simmons
24
Compliance with Section 16(a) Reporting
Based solely on the Companys records and information provided by our directors, executive officers and beneficial owners of more than 5% of the Common Stock, we believe that all reports required to be filed by our directors and executive officers under Section 16(a) of the Exchange Act were filed on a timely basis during 2014 except that, due to inadvertent errors, two grants of shares of restricted stock to Michael W. Lowry, Controller of the Company, were reported late (a grant of 300 shares of restricted stock on February 6, 2014 was reported on a Form 5 filed on February 5, 2015, and a grant of 1,416 shares of restricted stock on April 30, 2014 was reported on a Form 4 filed on May 6, 2014).
Stock Ownership by Management and the Board of Directors
The following table shows, as of March 5, 2015, the number of shares of Common Stock beneficially owned by each director and nominee, our NEOs and all current directors and executive officers of the Company as a group.
Name of Beneficial Owner |
Sole Voting and Investment Power (1) |
Other (2) | Aggregate Percentage Owned |
|||||||||
Stuart M. Essig |
18,706 | 0 | * | |||||||||
John W. Gerdelman |
13,635 | 0 | * | |||||||||
Lemuel E. Lewis |
20,356 | 0 | * | |||||||||
Martha H. Marsh |
7,186 | 0 | * | |||||||||
Eddie N. Moore, Jr. |
17,590 | 0 | * | |||||||||
James E. Rogers |
58,897 | 0 | * | |||||||||
Robert C. Sledd |
14,022 | 0 | * | |||||||||
Anne Marie Whittemore |
65,868 | 0 | * | |||||||||
David S. Simmons |
4,225 | 0 | * | |||||||||
Craig R. Smith |
155,712 | 0 | * | |||||||||
James L. Bierman |
95,872 | 0 | * | |||||||||
Richard A. Meier |
49,225 | 0 | * | |||||||||
Erika T. Davis |
70,003 | 0 | * | |||||||||
Charles C. Colpo |
58,588 | 0 | * | |||||||||
Grace R. den Hartog |
49,173 | 8,924 | * | |||||||||
Brian J. Shotto |
11,719 | 0 | * | |||||||||
All Executive Officers and Directors as a group (19 persons) |
797,979 | 19,134 | 1.29 | % |
* Represents less than 1% of the total number of shares outstanding.
(1) No officer or director of the Company has the right to acquire any shares through the exercise of stock options within 60 days following March 5, 2015.
(2) Includes: (a) shares held by certain relatives or in estates; (b) shares held in various fiduciary capacities; and (c) shares for which the shareholder has shared power to dispose or to direct disposition. These shares may be deemed to be beneficially owned under the rules and regulations of the SEC, but the inclusion of such shares in the table does not constitute an admission of beneficial ownership.
25
Stock Ownership by Certain Shareholders
The following table shows, as of March 5, 2015, any person (including any group as that term is used in Section 13(d)(3) of the Exchange Act) who, to our knowledge, was the beneficial owner of more than 5% of the Common Stock.
Name and Address of Beneficial Owner | Shares Beneficially Owned | Percentage Owned | ||||||
BlackRock, Inc. 55 East 52nd Street, New York, NY 10022 |
6,574,987 | (1) | 10.41 | % | ||||
FMR LLC 245 Summer Street, Boston, MA 02210 |
3,200,032 | (2) | 5.07 | % | ||||
Vanguard Group, Inc. 100 Vanguard Blvd., Malvern, PA 19355 |
4,377,924 | (3) | 6.93 | % |
(1) Based upon a Schedule 13G report or amendment filed by BlackRock, Inc. with the SEC on January 9, 2015.
(2) Based upon a Schedule 13G report or amendment filed by FMR LLC with the SEC on February 13, 2015.
(3) Based upon a Schedule 13G report or amendment filed by Vanguard Group, Inc. with the SEC on February 11, 2015.
Equity Compensation Plan Information
The following table shows, as of December 31, 2014, information with respect to compensation plans under which shares of Common Stock are authorized for issuance.
Plan Category |
(a) Number of securities to be issued upon exercise of outstanding options, warrants and rights |
(b) Weighted-average exercise price of outstanding options, warrants and rights |
(c) Number of securities |
|||||||||
Equity compensation plans approved by shareholders (1) |
15,000 | $ | 20.49 | 1,800,000 | ||||||||
Equity compensation plans not approved by shareholders (2) |
| | | |||||||||
Total |
15,000 | $ | 20.49 | 1,800,000 |
(1) These equity compensation plans are the 2003 Directors Compensation Plan and 2005 Stock Incentive Plan. No additional awards may be made under the 2003 Directors Compensation Plan. However, shares may be issued under such plan upon the exercise of options that remain outstanding under such plans.
(2) The Company does not have any equity compensation plans that have not been approved by shareholders.
26
COMPENSATION DISCUSSION AND ANALYSIS
This Compensation Discussion and Analysis (CD&A) describes our executive compensation philosophy and program, the compensation decisions made by the Compensation & Benefits Committee under this program and the considerations that went into the making of these decisions in light of the Companys performance in 2014.
Our fiscal year 2014 NEOs are:
Craig R. Smith | Executive Chairman | |
James L. Bierman | President & Chief Executive Officer | |
Richard A. Meier | Executive Vice President & Chief Financial Officer | |
Erika T. Davis | Senior Vice President, Administration & Operations | |
Charles C. Colpo | Senior Vice President, Strategic Relationships | |
Grace R. den Hartog | Senior Vice President, General Counsel & Corporate Secretary | |
Brian J. Shotto* | Former Senior Vice President, Manufacturer Services |
* Mr. Shotto resigned from the Company effective August 31, 2014.
Executive Summary
2014 Performance Highlights
For Owens & Minor, 2014 was a year of growth and continued advancement of our strategic vision while we managed through competitive pressures in the medical/surgical supply distribution and third party logistics markets, both domestic and international, and re-structured portions of our logistics operations abroad.
Highlights of 2014 performance include:
| Revenue Growth. Consolidated revenues for 2014 were $9.44 billion, an increase of $369 million, or 4.1%, when compared to 2013 revenues. Excluding the impact of $46.9 million in revenue from two acquisitions in 2014, consolidated revenues grew 3.5% for the year. |
| Acquisition of Medical Action Industries Inc. On October 1, 2014, we completed our acquisition of Medical Action Industries Inc., a leading producer of custom procedure trays and minor procedure kits, to broaden our service offering to provider and manufacturer customers and advance our strategy of Connecting the World of Medical Products to the Point of Care. |
| Acquisition of ArcRoyal. On November 1, 2014, we completed our acquisition of Ireland-based surgical kitting company ArcRoyal, complementing the Medical Action acquisition and the Companys existing unitized delivery capabilities by providing immediate access and global reach into European markets and beyond. |
| Continued Integration of Movianto. We acquired Movianto in August 2012 in order to establish a European platform and extend our global reach with new capabilities to serve our health care manufacturer customers. During 2014, we continued to focus heavily on the integration of Movianto, making key management changes, centralizing and streamlining processes and services and re-structuring operations to reduce costs and realize efficiencies. |
| Debt Refinancing. In the third quarter of 2014, Owens & Minor issued $275 million of 3.875% Senior Notes due 2021 and $275 million of 4.375% Senior Notes due 2024. We used the proceeds from these offerings of approximately $446 million to fund the acquisitions of Medical Action and ArcRoyal and to fund the early retirement of the Companys 6.35% Senior Notes due 2016. |
27
| Continued Improvement to Logistics Infrastructure. We continued initiatives to optimize our network of distribution facilities through closure of small, less efficient distribution centers and opening of larger regional distribution centers with capabilities to provide a broader range of services to both our provider and manufacturer customers. |
Despite strong revenue growth, significant strategic accomplishments, infrastructure improvements and efforts to assimilate our international operations in 2014, our NEOs did not receive a payout under our annual incentive program because we did not achieve an adjusted earnings per share target that was a condition to any payout based on other financial results. In addition, we did not achieve our two-year performance targets for performance shares issued in 2013 and, consequently, did not pay out any shares to our NEOs for the 2013-2014 performance cycle. However, after considering the significant achievements of management (described above) to improve overall operations and advance the Companys long-term strategy, the Compensation & Benefits Committee exercised its discretion to pay members of executive management a discretionary bonus of 10% of base salary (11.7% for the President & Chief Executive Officer). For more information about these discretionary bonuses, see Discretionary Bonuses on page 37 of this proxy statement.
Owens & Minors Compensation Philosophy and Goals
The fundamental principle underlying Owens & Minors executive compensation program is that we pay for performance and achievement of results. Our goal is to encourage sustained high Company and individual performance within a framework that allows us to attract, retain and motivate management. Components of our executive compensation program are designed to create the appropriate balance between short- and long-term incentives, to weigh cost against expected benefit and to align with shareholder value while promoting executive retention. These components include:
| Annual incentives to drive critical business goals for each year. |
| Restricted stock and performance share grants to retain management and focus executives on longer- term financial performance and execution of our strategic plan. |
| Reasonable but competitive base salaries so executives are not motivated to take excessive risks. |
| Retirement, severance and other benefits to attract executive talent and encourage retention. |
We believe that our executive compensation program, structured to reward performance and create long-term shareholder value, has played a significant role over the past decade in effectively motivating and rewarding management to meet the challenges of our business and produce our many successes. Additionally, we believe the program generally aligns pay and performance as demonstrated by the non-payment of incentive payouts for 2014 based on company financial results. Further discussion and disclosure of the Companys compensation policies and practices are included in the pages following this Executive Summary.
28
Summary of 2014 Pay Structure
29
Executive Compensation Practices
Our compensation program and practices are designed to meet compensation best practices and to drive performance that creates long-term shareholder value.
WHAT WE DO
þ Pay for Performance. We link pay to performance. A significant portion of our executives potential total annual compensation, both cash and equity, is based on the achievement of objective, simple and transparent financial measures that are structured to enhance short-term and long-term performance. |
þ Performance-Based Equity Awards. One-half of our annual equity award grants are performance shares with multi-year performance requirements and an additional year of restricted vesting on earned shares. |
þ Recoupment Policy. We have in place a recoupment policy to recover from our executives compensation paid under circumstances involving restatement of our financial statements due to misconduct. |
þ Share Ownership Guidelines. Our Management Equity Ownership Program establishes stock ownership guidelines and, until 2014, provided incentives for achieving the requisite levels of stock ownership. All of our NEOs exceed the established ownership guidelines. |
þ Limited Perquisites. We tie perquisites to a legitimate business purpose and limit the value provided to executive officers. |
þ Double-Triggered Change in Control Provisions. Equity vesting and severance payments and benefits based on a change in control require termination of employment following the change in control. |
þ Risk Mitigation. We mitigate risks associated with compensation by establishing caps on incentive compensation, multiple performance targets for earning incentive compensation and ongoing processes to identify and manage risk. We do not believe our compensation program creates risks that are reasonably likely to have a material adverse impact on the Company, which we confirm annually through a risk assessment of incentive-based compensation. |
þ Independent Compensation Consulting Firm. The Compensation & Benefits Committee receives advice about its programs and practices from an independent consulting firm that provides no other services to the Company and has no conflicts of interest with respect to its work. |
WHAT WE DONT DO
x No Employment Agreements. We do not have employment agreements with any of our NEOs. |
x No Hedging. We prohibit our executive officers and directors from hedging against the economic ownership of Company stock. |
x No Pledging. We strongly discourage our executive officers from pledging Company stock, and none of our NEOs currently has any such stock pledged. |
x No Re-pricing of Equity Awards. Our stock plans do not permit the re-pricing of equity awards. |
x No Tax Gross-Ups. We do not provide any tax gross-ups, including excise tax gross-ups on change in control severance payments and benefits. |
30
Say-On-Pay Vote
In May 2014, our shareholders approved the compensation of our NEOs for 2013 in our say-on-pay advisory vote with 94.6% of votes cast in support of the program. In light of this support, the Compensation & Benefits Committee made no material changes to the general structure and philosophy behind our executive compensation program in 2014. At the 2015 annual meeting, our shareholders will again hold an advisory vote to approve executive compensation for 2014. The Compensation & Benefits Committee will continue to consider results from this years and future advisory votes on executive compensation.
The Process for Setting Executive Compensation
The Companys executive compensation levels and programs are established, approved and administered by the Compensation & Benefits Committee of the Board of Directors, which is currently composed of four independent directors. The Compensation & Benefits Committee solicits the views of its outside consulting firm and senior management on incentive compensation and plan design issues. In addition, the Compensation & Benefits Committee evaluates the performance of our Chief Executive Officer on an annual basis jointly with the Governance & Nominating Committee, and the Chief Executive Officer provides performance evaluations of our other executive officers and recommendations as to their compensation levels.
Independent Advisor. The Compensation & Benefits Committee has the authority under its charter to retain independent consultants or advisors to assist it in gathering information and making decisions. Management may not engage any independent advisor retained by the Compensation & Benefits Committee to perform services without the prior approval of the committee, and no such engagement by management was undertaken in 2014. The Compensation & Benefits Committee also obtains information and assistance from the Companys Human Resources Department in evaluating and making decisions on executive compensation.
The Compensation & Benefits Committee engaged Semler Brossy Consulting Group, LLC (Semler Brossy) in 2014 as its independent advisor to (1) provide recommendations in changes to our peer group; (2) analyze competitive levels of each element of compensation and total compensation for each of the NEOs relative to our peer group and industry trends; (3) provide information regarding executive compensation trends and regulatory changes and developments; and (4) provide input on annual and long-term incentive design. The Compensation & Benefits Committee has analyzed whether the work of Semler Brossy has raised any conflict of interest and has concluded that the work of our advisor, including the individuals employed by our advisor who provide consulting services to the committee, has not created any conflict of interest. The Compensation & Benefits Committee also considered and confirmed the independence of legal advisors retained during 2014.
Factors Used to Determine Executive Compensation. Consistent with past years, the Compensation & Benefits Committee considered a variety of factors in making decisions regarding compensation for our NEOs in 2014. The primary factors were as follows:
Performance. Our policy is to provide executive officers with compensation opportunities that are based upon Company performance, their individual performance and their contribution to Company performance.
Mix of Short-Term and Long-Term Compensation. Because the successful operation of our business requires a long-term approach, one element of our executive compensation program is long-term compensation. Although we have never had specific policies on the percentage of total compensation that should be short-term versus long-term, we considered this relationship in determining the overall balance and reasonableness of our executives total direct compensation packages. We believe that short-term compensation is necessary in conjunction with long-term compensation to provide remuneration for performance of the short-term goals or milestones that ultimately lead to achievement of our long-term objectives and strategic initiatives.
Mix of Performance-Based Compensation. To create a strong link between pay and performance, a significant portion of compensation is based on the achievement of objective financial measures. We have no
31
specific policies on the percentage of total compensation that should be performance-based, but consider this relationship in determining the overall balance and reasonableness of the executives total direct compensation packages.
Impact and Mix of Cash vs. Non-Cash Compensation. We consider both the cost and the motivational value of the various components of compensation. Although we have no specific policies on the percentage of total compensation that should be cash versus equity, we consider this relationship in determining the overall balance and reasonableness of the executives total direct compensation packages.
Peer Group Comparisons. Each year, we evaluate our compensation levels and programs through comparisons to available information for a group of peer companies selected by the Compensation & Benefits Committee (Peer Companies) based in part on recommendations from and analyses prepared by our compensation advisors. This evaluation helps us to assess whether our level and mix of executive pay is competitive and reasonable when compared to certain industry standards.
For 2014, we used a peer group of 12 companies. In general, the Peer Companies were selected because they are in health care distribution or other distribution industries and have revenue, net income, total assets and/or market capitalization (the Size Indicators) that align reasonably closely with those of the Company. The peer group also includes MeadWestvaco Corporation, a Richmond, Virginia-based company with which we believe the Company competes geographically for executive talent. These Peer Companies are as follows:
2014 Peer Companies | ||
C.H. Robinson Worldwide, Inc. |
Patterson Companies, Inc. | |
Con-Way, Inc. |
Thermo Fisher Scientific Inc. | |
Genuine Parts Company |
United Natural Foods, Inc. | |
Henry Schein, Inc. |
United Stationers Inc. | |
JB Hunt Transport Services, Inc. |
W.W. Grainger, Inc. | |
MeadWestvaco Corporation |
||
Nash Finch Company |
Relative to the Size Indicators of the Peer Companies, the Company generally ranks between the 25th percentile and median of the peer group. Using the Peer Companies, Semler Brossy analyzed the compensation components and levels as reported for the named executive officer positions of the Peer Companies and prepared a comparison of 2014 target total direct compensation and each element thereof to reported information for the Peer Companies. Based on this analysis, the Compensation & Benefits Committee determined that it is appropriate to target total compensation for our NEOs up to the median relative to the Peer Companies and to pay above or below the target level based on actual performance. The target total direct compensation (sum of base salaries, annual incentive opportunities and equity awards) for all NEOs is below median relative to the Peer Companies, generally due to lower levels of equity awards.
Tally Sheets. We also review total compensation levels for executive officers at least annually through the use of tally sheets that quantify each element of direct and indirect compensation provided to individual executives and the portion of the executives total compensation represented by each element of compensation. This annual review of tally sheets also includes information on the value of executives unexercised stock options and outstanding stock awards as well as an evaluation of the payments and benefits that would be paid to executive officers in the event of termination of employment, including retirement or following a change in control of the Company. While providing additional context to us in making compensation decisions, the information from the tally sheets regarding unexercised stock options, outstanding stock awards and termination payments and benefits generally does not affect our compensation decisions for the NEOs. This reflects our view that an executives compensation level should be based on the Companys performance, the executives performance and the executives contribution to the Companys performance.
32
Total Program Cost. We consider the cost (including aggregate share usage and dilution) of the various components of our compensation program in evaluating the overall balance and reasonableness of our executives total direct compensation packages.
Risk Considerations. In setting executive compensation, the Compensation & Benefits Committee reviews the various components of our program to consider whether they are appropriately structured to promote the achievement of our business goals without encouraging the taking of unnecessary risks. We believe that several elements of our program mitigate risks associated with performance-based compensation, including the following:
| Limits on Incentive Compensation. Awards under our annual incentive program are capped at 200% of the executives target award to protect against excessive short-term incentives, and the Compensation & Benefits Committee has discretion to reduce awards based on factors it deems appropriate, including whether officers took unnecessary risks. |
| Performance Metrics. We use a combination of financial performance metrics (net revenue, net income and return on average assets) for our annual incentive program that emphasizes profitable and disciplined growth and requires responsible and risk-based decision- making by our executives. |
| Performance Shares/Long-Term Equity Awards. Approximately one-half of an executives equity compensation each year consists of performance shares with a two-year performance cycle and an additional year of service-based vesting, which focuses management on sustaining the Companys longer-term performance. The other half of an executives equity compensation each year consists of restricted stock awards that vest over a period of at least three years and, accordingly, further encourages a focus on long-term performance. |
| Share Ownership Guidelines. Our share ownership guidelines ensure that our executives have a substantial stake tied to long-term holdings in Owens & Minor stock. |
33
Elements of Compensation
In an effort to achieve the objectives identified above, our executive compensation framework consists of the following elements as further described below:
Element | Description | Purpose | ||
Base Salary | Fixed cash | Provides a fixed amount of cash compensation to allow us to recruit and retain key talent | ||
Annual Incentives | Cash awarded annually for performance against revenue, income, return on average assets and qualitative performance factor | To motivate executive officers performance in achieving our current-year business goals | ||
Long-Term Incentives | Performance shares and restricted stock
Restricted stock vests 3 years from date of grant
Performance shares are earned if the Company achieves goals on consolidated operating earnings, domestic operating earnings, and international operating earnings. Performance is measured over a 2-year period and, if earned, shares vest at the end of 3 years from date of award |
Rewards performance that enhances shareholder value through the use of equity-based awards that link compensation to the value of our Common Stock and the achievement of multi-year performance goals; strengthens the alignment of management and shareholder interests by creating meaningful levels of Company stock ownership by management | ||
Deferred Compensation Plan | Officers may defer salary and cash bonuses into a plan that provides for investment options similar to the Companys 401(k) plan | Provides a tax efficient opportunity to save for retirement and to ensure that our executive compensation program remains competitive in the marketplace for key executive talent | ||
Retirement/Post-Termination Compensation |
Participation in Companys 401(k) plan and matching contributions similar to other teammates. SERP (frozen as of March 2012) | Provides security for the future needs of the executives and their families |
We believe that the elements of our executive compensation framework support short-term and long-term performance goals by providing our executive officers with an appropriate mix of compensation elements that include (1) fixed annual compensation, (2) target-based annual and long-term incentive compensation and (3) security for the future needs of the executives and their families in the form of retirement and termination benefits.
34
Base Salary
All of our executive officers are employed on an at will basis, and there are no employment agreements. We review base salaries each April.
In making base salary decisions in April 2014, the Compensation & Benefits Committee considered:
(1) Individual attributes of each NEO (such as responsibilities, skills, leadership and experience),
(2) Individual and overall Company performance levels,
(3) The officers expected future contributions to the Company, and
(4) Overall market-competitiveness of the officers base salary.
We also considered that the targeted average percentage salary increase for non-executive Company teammates was approximately 2.0% in 2014. In addition, we reviewed competitive comparisons prepared by Semler Brossy indicating that our base salary levels were generally above median versus the Peer Companies even though target total direct compensation was below the median. Based on the factors above, we gave each of the NEOs a merit increase in base salary of up to 2.0%. We believed that these relatively modest increases in salary levels reflect the performance of each of the officers balanced against economic conditions, average salary increases being received by other Company teammates and the Companys above-median base salary levels relative to the Peer Companies. In addition, as reflected in the table below, Mr. Bierman received an increase in base salary due to his promotion to President & Chief Executive Officer and Ms. den Hartog received an additional adjustment based on her assumption of additional responsibilities for regulatory functions and resulting additional direct reports.
Name | 2014 Base Salary Amount |
2014 Base Salary Increase Percentage |
Reason for Increase | |||||||
Craig R. Smith (1) |
923,186 | 2 | % | Merit | ||||||
James L. Bierman (2) |
850,000 | 21 | % | Merit and promotion to President & Chief Executive Officer | ||||||
Richard A. Meier |
586,500 | 2 | % | Merit | ||||||
Erika T. Davis |
504,900 | 2 | % | Merit | ||||||
Charles C. Colpo |
434,879 | 2 | % | Merit | ||||||
Grace R. den Hartog (3) |
445,000 | 7 | % | Merit and assumption of additional responsibilities | ||||||
Brian J. Shotto |
495,000 | 0 | % | N/A |
(1) Mr. Smiths base salary was reduced from $923,186 to $750,000 effective September 1, 2014 when he moved from the Chairman & Chief Executive Officer position to Executive Chairman.
(2) Mr. Bierman received a 2% merit increase in April 2014 for a base salary of $714,000 and an additional increase to $850,000 effective September 1, 2014 when he was promoted to President & Chief Executive Officer.
(3) In April 2014, Ms. den Hartog received a 2% merit increase plus an additional 4.58% adjustment to reflect the assumption of additional responsibilities for regulatory functions and resulting additional direct reports.
35
Annual Incentives
We provide annual incentive opportunities to executive officers to motivate their performance in achieving our current-year business goals. Each year, we establish a business plan for the forthcoming year that includes financial, strategic and other goals for the Company and that is approved by the Board of Directors. Annual incentive goals for the executive officers are set based on the approved business plan (the Annual Incentive Program). These goals are weighted to reflect their relative importance and contribution to overall Company performance.
For the 2014 Annual Incentive Program and consistent with past years, the Compensation & Benefits Committee set target annual incentive opportunities at 75% of base salary for the Chief Executive Officer and 50% of base salary for each of the other NEOs, subject to the achievement of the Companys established performance goals. The Chief Executive Officer has a higher Target Payout Amount than the other NEOs, reflecting the broader scope of his responsibilities and authority and his greater ability to impact the Companys performance.
The performance metrics (Performance Metrics) established for determining the Target Payout Amount that could be paid were:
| Company Net Revenue |
| Company Net Income |
| Company Return on Average Assets |
| A Qualitative Performance Factor |
In addition, none of the foregoing Performance Metrics could result in a payout unless the Company achieved an adjusted diluted EPS for 2014 of at least $1.80 (the EPS Qualifier).
The Compensation & Benefits Committee selected, and the Board of Directors approved, the EPS Qualifier and each of the Performance Metrics, including the weights assigned to them and the target achievement levels in March 2014 based on discussions with and recommendations by senior management, the approved business plan for 2014 and the growth and operational improvements called for in our strategic plan. The specific financial Performance Metrics were selected because net income and net revenue, together with effective asset management, are the most critical performance areas for the Company and key indicators of successful growth and management. They also constitute simple, objective and transparent criteria by which to measure performance.
In addition, in 2014, the Compensation & Benefits Committee introduced a Qualitative Performance Factor as an additional performance metric that, subject to meeting the EPS Qualifier, would allow a portion of any incentive compensation earned by the NEOs to be based on an overall assessment of the NEOs job performance relative to leadership, goal implementation, strategic focus, management skills and other factors. The Compensation & Benefits Committee believed it was important to include the Qualitative Performance Factor as a way to reward strong performance and leadership provided by management that may or may not have translated into achievement of other financial and operating targets during the year, but that were nonetheless important achievements believed to contribute to future value creation.
The Compensation & Benefits Committees goal in setting the target achievement levels was to provide management with challenging yet what it believed were reasonably achievable goals that would lead the Company to meeting its 2014 business plan and position us to ultimately achieve the growth and improvement targets in our strategic plan without encouraging excessive risk-taking behavior. We believe that the use of three different financial performance metrics that reward revenue growth but emphasize profitable growth with effective asset management as well as a qualitative performance metric to assess individual efforts and goal achievement provides a balanced assessment of performance. The Compensation & Benefits Committee retains authority to reduce or eliminate incentive compensation, which allows us to monitor and respond to any behavior that we believe could be detrimental to the Company.
36
The achievement levels for the financial Performance Metrics were structured to provide for a Target Payout Amount as well as a maximum of two times the Target Payout Amount and a threshold of 25% of the Target Payout Amount. No amount would be payable in respect of any Performance Metrics for achievement below the Threshold Payout Amount or if the Company did not achieve the EPS Qualifier.
The table below sets forth (i) the four Performance Metrics, their respective weightings, achievement levels at threshold, target and maximum as well as actual results in 2014 for each financial Performance Metric and (ii) the EPS Qualifier and actual achievement level required for the payment of any incentive compensation under the Annual Incentive Program.
2014 Performance Metric Achievement Levels and Actual Results
Performance Metrics | Weighting |
Threshold (1) 25% |
Target (1) 100% |
Maximum (1) 200% |
2014 Actual Results |
2014 Actual Achievement | ||||||||||||||
Company Net Revenue ($ thousands) |
20% | $ | 8,810,000 | $ | 9,177,000 | $ | 9,544,000 | $ | 9,440,000 | 172% | ||||||||||
Company Net Income (2) ($ thousands) |
40% | $ | 109,000 | $ | 128,000 | $ | 144,000 | $ | 110,000 | 29% | ||||||||||
Company Return on Average Assets |
20% | 5.0% | 5.4% | 5.8% | 4.3% | 0% | ||||||||||||||
Qualitative Performance Factor |
20% | N/A | N/A | N/A | N/A | N/A | ||||||||||||||
EPS Qualifier for Receipt of Any Incentive Compensation Payout (3) |
N/A | $ | 1.80 | $ | 1.80 | $ | 1.80 | $ | 1.76 | No |
(1) For achievement levels above threshold but below target or above target but below maximum, payout amounts would be calculated based on a straight-line interpolation of the achievement level above threshold or target, as applicable.
(2) For purposes of the 2014 Annual Incentive Program, actual results exclude the following (net of tax) from net income: acquisition-related costs and exit and realignment charges of $35.3 million, loss on early retirement of debt of $9.1 million, fair value adjustments related to purchase accounting of $(4.7) million and an accrual for a breach of contract settlement of $3.9 million.
(3) For purposes of the 2014 Annual Incentive Program, the EPS Qualifier was based on adjusted net income as described in footnote (2) above.
Because the Company did not achieve the EPS Qualifier of at least $1.80 per share, no incentives were paid under the Annual Incentive Program to the NEOs for 2014 performance.
Discretionary Bonuses
Despite non-achievement of the EPS Qualifier under the 2014 Annual Incentive Program that prevented a payout to our executive officers, the Compensation & Benefits Committee determined to award each of the current NEOs discretionary bonuses as shown in the table below for the following reasons:
| The executive officers successfully implemented strategic goals of the Company in 2014 by completing the acquisition of both a domestic and an international kitting company to enhance the Companys product offerings and unitized product delivery capabilities in the United States and |
37
abroad. The Compensation & Benefits Committee believes that these acquisitions provide the platform for future growth and capabilities to realize financial results following successful integration. |
| The executive officers continued to implement significant measures both domestically and abroad to make the Companys supply chain infrastructure more efficient and streamlined. |
| The Compensation & Benefits Committee wanted to provide some level of recognition of the management teams success in accomplishing certain of the Companys strategic goals and managing through challenges in the marketplace and operations despite non-achievement of payouts under the 2014 Annual Incentive Program and believed that the discretionary bonuses awarded were conservative in amount yet an acknowledgement of forward progress by the Company. |
| While the Compensation & Benefits Committee considered that the discretionary bonuses would not qualify as performance-based compensation under Section 162(m) of the IRC, it believed that the acknowledgement of senior managements efforts and progress in creating a platform for growth and improved efficiency outweighed the potential non-deductibility of a portion of these bonuses. |
Name | Bonus Amount* | |||
Craig R. Smith |
$ | 75,000 | ||
James L. Bierman |
99,167 | |||
Richard A. Meier |
58,650 | |||
Erika T. Davis |
50,490 | |||
Charles C. Colpo |
43,488 | |||
Grace R. den Hartog |
44,500 |
* Bonus amounts were calculated at 10% of each NEOs base salary except that Mr. Biermans bonus was 11.7% of base salary.
Long-Term Incentives
The Companys long-term incentive program is focused on rewarding performance that
| enhances shareholder value through the use of equity-based awards that link compensation to the value of our Common Stock and achievement of multi-year performance goals, and |
| strengthens the alignment of management and shareholder interests by creating meaningful levels of Company stock ownership by management. |
Our long-term incentive program had two components in 2014: (1) annual equity awards and (2) the Management Equity Ownership Program (MEOP). Although the NEOs received equity dividends under the MEOP in 2014 relative to achieving the requirements of that program as of the end of 2013, effective for calendar year 2014 and beyond, we have discontinued future payment of MEOP dividends to our executives for achieving and maintaining Common Stock ownership levels under the MEOP. Instead, the committee will take prior MEOP dividend amounts and continuing stock ownership expectations into consideration in establishing long-term incentive grant guidelines for the executive officers.
In accordance with our standard practice, the grant of the 2014 annual equity awards was made at the first meeting of our Board in 2014 on February 6, 2014, a date that is scheduled more than one year in advance. The grant values are based on the closing price of the stock on the date of grant and the number of shares subject to the award. The Companys equity grants to officers consist of restricted stock and performance shares subject to three-year vesting periods; the Company has not issued stock options to its officers since 2007.
38
When making 2014 long-term incentive equity award determinations, the Compensation & Benefits Committee focused on the Companys longer-term financial performance and balanced the need to align the NEOs financial interests with those of shareholders against considerations regarding the affordability of equity grants, including aggregate share usage, dilution and accounting costs. We have historically been conservative and below median relative to the Peer Companies in granting equity awards under our long-term incentive program to minimize share usage, dilution and accounting costs.
Pursuant to the Companys long-term incentive program, the NEOs received long-term incentive awards in 2014 having the following grant date fair values:
2014 Long-Term Incentive Awards (1) | ||||||||||||||||
Name | Performance Shares (2) |
Restricted Stock (3) |
MEOP Stock (4) |
Total | ||||||||||||
Mr. Smith |
$ | 400,005 | $ | 400,005 | $ | 204,200 | $ | 1,004,210 | ||||||||
Mr. Bierman |
705,014 | 705,014 | 184,757 | 1,594,785 | ||||||||||||
Mr. Meier |
200,002 | 200,002 | 90,397 | 490,401 | ||||||||||||
Ms. Davis |
162,494 | 162,494 | 33,043 | 358,031 | ||||||||||||
Mr. Colpo |
105,005 | 105,005 | 37,442 | 247,452 | ||||||||||||
Ms. den Hartog |
162,494 | 162,494 | 33,983 | 358,971 | ||||||||||||
Mr. Shotto |
162,494 | 162,494 | 46,878 | 371,866 |
(1) The amounts shown are the aggregate grant date fair value of the awards computed in accordance with FASB ASC Topic 718 and, in the case of performance shares, are based on probable achievement at target levels.
(2) These performance shares generally require achievement by the Company of specific financial metrics (discussed below) for fiscal years 2014 and 2015 as a condition to issuance of the underlying restricted stock (which, if earned, would vest on the third anniversary of the performance share award). Of the performance shares awarded to Mr. Bierman, $455,011 were awarded in connection with his promotion in September 2014 to President & Chief Executive Officer, are based on achievement of specified performance metrics during fiscal year 2015 and, if earned, would be immediately vested.
(3) These shares of restricted stock vest three years from the date of grant based on the executives continued employment with the Company. Of the restricted stock awards to Mr. Bierman, $455,011 was awarded in connection with his promotion in September 2014 to President & Chief Executive Officer.
(4) These awards were granted in February 2014 and were based on the officers achievement of their respective 2013 target ownership amounts under the MEOP as of December 31, 2013. Each officer, except Mr. Bierman, Mr. Meier and Mr. Shotto, received his or her award in additional performance shares (described in (2) above). Awards to Mr. Bierman, Mr. Meier and Mr. Shotto were paid in shares of restricted stock that vest five years from the date of grant. See discussion of our MEOP on page 41 of this proxy statement.
Annual Equity Awards. Our shareholder-approved 2005 Stock Incentive Plan permits us to award grants of non-qualified stock options, incentive stock options, stock awards, performance share awards and stock appreciation rights. Except in instances of initial executive hiring, job promotions and similar circumstances, we grant equity awards to executive officers one time each year. The Compensation & Benefits Committees decision to grant equity-based awards is discretionary and largely determined by the Companys longer-term financial performance, strategic accomplishments and individual contributions. Equity award decisions may also be based upon outstanding individual performance, expected future performance, job promotions and the
39
assumption of greater responsibility within the Company. We strive to maintain an appropriate balance between the aggregate number of shares used for equity grants (relative to the competitive landscape) and shareholder interests.
In 2014, the Compensation & Benefits Committee granted equity awards to the NEOs consisting of 50% service-based restricted stock that vests three years from the date of grant and 50% performance shares, which are earned only if the Company achieves specified financial metrics for calendar years 2014 and 2015. If performance requirements are met, the performance shares are paid in the form of restricted stock that vests on the third anniversary of the performance share award. If performance requirements are not met, the award is forfeited.
Prior to 2013, performance share grants were based on achievement of a single operating earnings metric. In 2013, we established three separate and weighted metrics for the performance share grant to include consolidated operating earnings, domestic operating earnings and international average return on invested capital (ROIC). In 2014, we replaced the international ROIC metric with an international operating earnings metric to focus officers on profitably growing both our domestic and international operations while maintaining the overall operating earnings metric to reflect total Company performance. The table below shows the metrics, weights and performance levels established for the 2014 performance share awards.
2014 Performance Share Achievement Metrics
Performance Metric (1) | Weight | Maximum 200% |
Target 100% |
Minimum >0 |
||||||||||||
Growth in Adjusted Consolidated Operating Earnings |
50 | % | $ | 65,000,000 | $ | 25,000,000 | >0 | |||||||||
Growth in Adjusted Domestic Operating Earnings |
30 | % | $ | 45,000,000 | $ | 15,000,000 | >0 | |||||||||
Growth in Adjusted International Operating Earnings |
20 | % | $ | 18,000,000 | $ | 10,000,000 | >0 |
(1) For achievement levels above the minimum amount but below target, or above target but below maximum, share payout amounts would be calculated based on a straight line interpolation of the achievement level above minimum or target, respectively. There is no payout for achievement below minimum.
(2) The metrics are measured over the 2014 and 2015 calendar years relative to 2013 actual performance, and based on the applicable weights and achievement levels, if met, will result in the issuance of restricted stock to each officer.
Because the performance metric for the performance shares awarded in 2014 has a two-year performance period, no restricted shares would be issued until after December 31, 2015 and only if one or more of the metrics are achieved at the minimum level or above. No restricted shares were issued in respect of performance shares awarded in 2013 due to non-achievement of requisite operating earnings growth for 2013 and 2014. The Company was required to achieve growth in each of consolidated operating earnings and domestic operating earnings during 2013 and 2014 relative to consolidated operating earnings and domestic operating earnings for 2012 and a minimum ROIC for 2013 and 2014 of 0.7%; the Company did not achieve growth in either consolidated or domestic operating earnings over the 2013 and 2014 period and the ROIC for the period was (1.4)%.
40
Management Equity Ownership Program & Ownership Guidelines. In addition to the equity awards discussed above, in 2014, each NEO received an additional equity ownership dividend award of restricted stock or performance shares by achieving requisite stock ownership levels as of December 31, 2013 under the Companys MEOP. Beginning with the 2014 calendar year, equity awards will no longer be made to officers under the MEOP for achieving or maintaining the requisite Common Stock target ownership levels although the ownership levels expected to be achieved and maintained will continue in effect. The MEOP is intended to further strengthen the alignment of management and shareholder interests with the following target ownership levels:
Officer |
Value of Common Stock | |||
Chief Executive Officer |
6.0 x Base Salary | |||
President |
3.0 x Base Salary | |||
Executive Vice Presidents |
2.0 x Base Salary | |||
Senior Vice Presidents |
1.5 x Base Salary | |||
Vice Presidents, Regional Vice Presidents |
1.0 x Base Salary |
The Chief Executive Officers higher ownership target reflects the larger portion of his total compensation represented by long-term incentive award value. Eligible holdings in meeting these targets include direct holdings, indirect holdings, shares held through Company plans such as the 401(k) plan and teammate stock purchase plan, and restricted stock holdings (but excluding stock options).
Under the MEOP, participants are given approximately five years to reach the full target ownership amount with interim targets to meet each year. As of December 31, 2014, each NEO had achieved his or her applicable target ownership amount. Because of the success of the MEOP in increasing and maintaining meaningful stock ownership levels among management, the Company has not imposed any further stock retention requirements on its executive officers in connection with stock option exercises or vesting of restricted stock.
Until discontinuation of the equity dividend beginning with calendar year 2014 and provided the applicable interim ownership targets were achieved, a 10% annual equity ownership dividend was paid on all Common Stock owned up to the participants full target ownership amount. The dividend was paid in the form of restricted stock that vests five years from the date of grant if the desired ownership level is maintained and the executive remains in the Companys employ. Once a participant reached his or her total target level of ownership, the annual equity ownership dividend was reduced from 10% to 5% and was paid in performance shares rather than shares of service-based restricted stock.
Because the equity dividend feature of the MEOP has now been discontinued, the Compensation & Benefits Committee will consider the MEOP dividend amounts that previously would have been received as well as the continued expected stock ownership levels in establishing long-term incentive grant guidelines for the executive officers.
Proposed 2015 Stock Incentive Plan
In connection with the expiration of the Companys 2005 Stock Incentive Plan in 2015, the Compensation & Benefits Committee has approved, adopted and submitted for shareholder approval the proposed 2015 Stock Incentive Plan which is more fully discussed under Approval of the Proposed Owens & Minor, Inc. 2015 Stock Incentive Plan beginning on page 16 of this proxy statement.
Retirement/Post-Termination Compensation
Retirement Compensation
The Company believes that retirement compensation is an essential component of an overall market competitive total executive compensation package in that it provides security for the future needs of the executives and their families. The NEOs are entitled to participate in the Companys 401(k) plan and receive Company matching contributions in the same manner as other Company teammates.
41
The Company provides supplemental retirement benefits under a Supplemental Executive Retirement Plan (the SERP) for certain officers selected by the Compensation & Benefits Committee, including certain of the NEOs, as further described on page 51 of this proxy statement under Retirement PlansSupplemental Executive Retirement Plan. At the time of its implementation in 1991, the SERP was designed to be competitive relative to defined benefit pension plans offered by other companies and to reward officers who provide long- term service to the Company, thereby promoting retention of highly performing executive talent. In 2012, the Compensation & Benefits Committee amended the SERP to freeze benefit levels and participants effective March 31, 2012, as part of an effort to make our overall executive compensation program more performance- based. Of the NEOs, Mr. Smith, Mr. Bierman, Ms. Davis, Mr. Colpo and Ms. den Hartog are participants in the SERP.
Deferred Compensation Plan
The Company has an Executive Deferred Compensation and Retirement Plan into which officers and other management-level personnel may defer salary and cash bonus. The purpose of the deferred plan is to provide security for current and future needs of the participants and their families by providing a tax efficient opportunity to save for retirement and to ensure that our compensation program remains competitive in the marketplace for key management talent. This plan provides for the same investment options as are available under our 401(k) plan (other than the Company stock fund option). For participants in this plan, the Company matches a total of up to 5% of 401(k) and deferred compensation plan contributions combined; provided that the participant has first maximized contributions under the 401(k) plan.
Change in Control Agreements
The Company has entered into change in control agreements (CIC Agreements) with certain officers, including certain of the NEOs, as described on page 56 of this proxy statement under Potential Payments upon Termination or Change in ControlChange in Control Agreements. The purpose of the CIC Agreements is to encourage key management personnel to remain with the Company and to help avoid distractions and conflicts of interest in the event of a potential or actual change in control of the Company so that executives will focus on a fair and impartial review of the acquisition proposal and the maximization of shareholder value despite the risk of losing their employment. The Compensation & Benefits Committee believes that the CIC Agreements help it to attract and retain key executive talent that could have other employment alternatives that may appear to be less risky absent these arrangements. The committee further believes that it has structured these agreements to be reasonable and to provide a temporary level of income protection to the executive in the event of employment loss due to a change in control.
The CIC Agreements do not provide for excise tax gross-up payments. In addition, the severance payment obligation under the CIC Agreements has a double trigger such that the payment of a severance benefit may only be made if there is a change of control and the officers employment with the Company is terminated by the Company without cause or the officer for good reason within 24 months after such change in control. We believe that this structure strikes an appropriate balance between the incentives and the executive hiring and retention effects described above, without providing these benefits to executives who continue to enjoy employment with an acquiring company in the event of a change of control transaction. Annually in connection with the review of executive compensation tally sheets, the Compensation & Benefits Committee reviews the severance amounts that would be payable to each named executive officer upon a change in control to ensure that the amounts are reasonable in light of the purpose of the agreements and relative to the marketplace generally. However, these amounts did not affect the committees compensation decisions with regard to any specific element of our 2014 executive compensation program.
Equity awards have the same double-trigger feature discussed above for accelerated vesting and exercisability, as applicable, in the event of a change in control. These same terms apply to the equity awards of all other teammates in the Company upon a change in control.
42
Severance Policy
We have a formal severance policy described on page 56 of this proxy statement under Potential Payments upon Termination or Change in ControlSeverance Policy that applies to all corporate officers who are involuntarily terminated without cause (or who resign at the request of the Company). We adopted this policy to promote management stability and provide consistent and fair treatment to our departing officers in circumstances where their performance does not constitute cause for employment termination. We believe the severance policy helps the Company attract and retain key executive talent that could have other employment alternatives that may appear to be less risky absent such a policy. The severance policy is designed to provide the officer with continued compensation and assistance for up to 18 months, depending on years of service with the Company, in an effort to assist him or her in finding new employment and is conditioned upon the officer entering into a non-competition, non-solicitation and confidentiality agreement for the benefit of the Company.
Other Benefits
In addition to the components of compensation discussed above, we provide certain other limited benefits to executives, including the NEOs, to help maximize the time key executives are able to spend on the Companys business; to reward experience, expertise, responsibility, seniority, leadership qualities and advancement; and to ensure that our executive compensation program remains competitive in the marketplace for key executive talent. These other benefits consist of the following and are specifically disclosed by amount in note 4 to the Summary Compensation Table on page 46 of this proxy statement: funding of life insurance policy premiums (provides security for current and future needs of the executives and their families), automobile allowance or lease (ensures transportation for business travel needs, recognizing that the automobile may also be used for personal purposes), tax and financial planning and return preparation assistance (allows executives to concentrate on business matters rather than on personal financial planning), and annual physical and enhanced medical access (identifies and addresses medical issues and helps preserve the Companys investment in its executives by encouraging them to maintain healthy lifestyles and be proactive in addressing potential health issues). In addition, NEOs may participate in our health and welfare plans, 401(k) plan and teammate stock purchase plan on the same basis as other full-time teammates. Finally, except under limited and unusual circumstances, we only pay for executive travel on commercial or private aircraft when such travel is integrally and directly related to the performance of the executives duties for the Company and is not personal in nature. We do not provide tax gross-ups on any income executives may realize as a result of the foregoing benefits.
Recoupment Policy
In an effort to mitigate any imprudent risk-taking behavior associated with incentive compensation, the Company has a policy that permits the recoupment of performance-based cash and equity compensation paid to executive officers. This compensation is recoverable from an executive officer if:
(i) | The payment or award was predicated upon the achievement of certain financial results that were subsequently the subject of a restatement of the Companys financial statements; |
(ii) | The Board (or its designated Compensation & Benefits Committee) determines that the executive engaged in misconduct that caused or substantially caused the need for the restatement; and |
(iii) | A lower payment would have been made to the executive officer based upon the restated financial results. |
If the foregoing conditions are met, as determined by the Board (or its designated committee), the Company, under terms of the applicable program or award agreements, will recover from the executive officer the amount by which his or her performance-based compensation for the relevant period exceeded the amount (if any) that would have been paid based on the restated financial results. The Board (or its designated committee) may take such further action as it deems necessary or appropriate to remedy the misconduct and prevent its recurrence. The recoupment policy currently will not apply to performance-based compensation after the second anniversary of the date on which such compensation was paid.
43
Hedging and Derivatives Trading Prohibition
The Company has policies that prohibit directors, officers and other teammates with access to confidential information of the Company from engaging in certain transactions relating to our common stock, including buying or selling options and short sales. We also prohibit these individuals from hedging the economic risk of ownership of our common stock and strongly discourage holding our stock in a margin account or pledging our stock as collateral for a loan.
Tax Considerations
Section 162(m) of the Internal Revenue Code disallows corporate tax deductions for executive compensation in excess of $1 million paid annually to the NEOs other than the Chief Financial Officer. This law allows for certain exemptions to the deduction cap, including performance-based compensation as defined in the rules adopted under Section 162(m).
Although the Company prefers that its pay plans be performance-based and therefore eligible for compensation expense deductions, it also believes that, under certain circumstances, awarding compensation that is not tax deductible may better support the long-term goals of the Company and the interests of shareholders. In 2014, each of Mr. Smith and Mr. Bierman had compensation that was nondeductible because it exceeded the $1 million allowance under Section 162(m).
Chief Executive Officer Compensation
Our compensation policies are applied in the same manner to all executive officers, including the Chief Executive Officer. The 2014 total direct compensation for each of Mr. Smith and Mr. Bierman, each of whom served in the Chief Executive Officer position in 2014, was higher than that of certain other NEOs to reflect the significant differences in the relative responsibilities and authority of those in the Chief Executive Officer position relative to the other officers. We believe that the scope of the Chief Executive Officers responsibilities and authority, together with his ability to impact the Companys performance, is significantly greater than that of the other NEOs and, accordingly, is reflected in his compensation. The differential in each of Mr. Smiths and Mr. Biermans compensation relative to certain other executive officers also is consistent with the compensation structures of the Peer Companies and thus reflects market differentials for the chief executive officer position versus other executives.
REPORT OF THE COMPENSATION & BENEFITS COMMITTEE
The Compensation & Benefits Committee has reviewed and discussed with management the Compensation Discussion and Analysis contained in this proxy statement. Based on this review and discussion, the committee has recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this proxy statement and incorporated by reference into the Companys Annual Report on Form 10-K for the year ended December 31, 2014.
THE COMPENSATION & BENEFITS COMMITTEE
Robert C. Sledd, Chairman
Stuart M. Essig
Martha H. Marsh
James E. Rogers
44
The following table summarizes for the years ended December 31, 2014, 2013 and 2012, as applicable, the total compensation of our NEOstwo individuals who served as Chief Executive Officer during 2014, our Chief Financial Officer, our three other most highly compensated executive officers and one additional former officer.
(a) | (b) | (c) | (d) | (e) | (f) | (g) | (h) | (i) | (j) | |||||||||||||||||||||||||||
Name and Principal Position |
Year | Salary ($) | Bonus ($) |
Stock (1) ($) |
Option ($) |
Non-Equity Incentive Plan Compensation (2) ($) |
Change in Value and Non-Qualified |
All Other ($) |
Total ($) |
|||||||||||||||||||||||||||
Craig R. Smith (5) Executive Chairman (former Chief Executive Officer) |
|
2014 2013 2012 |
|
$
|
895,888 898,941 878,391 |
|
$
|
75,000 0 0 |
|
$
|
1,004,210 986,161 1,084,120 |
|
$
|
0 0 0 |
|
$
|
0 0 0 |
|
$
|
1,812,044 0 1,024,137 |
|
$
|
99,080 79,618 46,391 |
|
$
|
3,886,222 1,964,720 3,033,039 |
| |||||||||
James L. Bierman (6) President & Chief Executive Officer |
|
2014 2013 2012 |
|
$
|
781,157 645,192 591,267 |
|
$
|
99,167 0 0 |
|
$
|
1,594,785 843,055 567,167 |
|
$
|
0 0 0 |
|
$
|
0 0 0 |
|
$
|
903,140 0 516,615 |
|
$
|
38,229 44,750 27,549 |
|
$
|
3,416,478 1,532,997 1,702,598 |
| |||||||||
Richard A. Meier (7) Executive Vice President & Chief Financial Officer |
|
2014 2013 2012 |
|
$
|
605,157 473,269 |
|
$
|
58,650 0 |
|
$
|
490,401 1,099,975 |
|
$
|
0 0 |
|
$
|
0 0 |
|
$
|
|
|
$
|
27,005 560,252 |
|
$
|
1,181,213 2,133,496 |
| |||||||||
Erika T. Davis Senior Vice President, Administration & Operations |
|
2014 2013 2012 |
|
$
|
520,972 441,331 397,587 |
|
$
|
50,490 0 0 |
|
$
|
358,031 490,158 370,808 |
|
$
|
0 0 0 |
|
$
|
0 0 0 |
|
$
|
612,818 0 330,614 |
|
$
|
27,208 34,866 30,134 |
|
$
|
1,569,519 966,355 1,129,143 |
| |||||||||
Charles C. Colpo Senior Vice President, Strategic Relationships |
|
2014 2013 2012 |
|
$
|
448,734 426,432 444,390 |
|
$
|
43,488 0 0 |
|
$
|
247,452 234,136 271,189 |
|
$
|
0 0 0 |
|
$
|
0 0 0 |
|
$
|
681,124 0 405,819 |
|
$
|
185,331 31,268 27,151 |
|
$
|
1,606,129 691,836 1,148,549 |
| |||||||||
Grace R. den Hartog Senior Vice President, General Counsel & Corporate Secretary |
|
2014 2013 2012 |
|
$
|
452,562 414,418 403,545 |
|
$
|
44,500 0 0 |
|
$
|
358,971 355,994 371,655 |
|
$
|
0 0 0 |
|
$
|
0 0 0 |
|
$
|
698,306 0 375,999 |
|
$
|
19,391 21,976 15,145 |
|
$
|
1,573,730 792,388 1,166,344 |
| |||||||||
Brian J. Shotto (8) Former Senior Vice President, Manufacturer Services |
|
2014 2013 2012 |
|
$
|
352,212 473,921 |
|
$
|
0 0 |
|
$
|
371,866 474,302 |
|
$
|
0 0 |
|
$
|
0 0 |
|
$
|
|
|
$
|
851,664 34,276 |
|
$
|
1,575,742 982,499 |
|
(1) The amounts included in column (e) are the aggregate grant date fair value of the awards computed in accordance with FASB ASC Topic 718, and column (e) includes awards subject to performance conditions. Of the total awards reflected in column (e) for 2014, the amount specified below for each officer represents awards subject to performance conditions, which are valued at the grant date based on probable achievement at target levels:
Mr. Smith, $604,205; Mr. Bierman, $705,014; Mr. Meier, $200,002; Ms. Davis, $195,537; Mr. Colpo, $142,447; Ms. den Hartog, $196,477; Mr. Shotto, $162,494.
45
The grant date value of the above performance-based awards for 2014 would equal the following for each officer assuming achievement of the highest level of performance conditions:
Mr. Smith, $1,208,410; Mr. Bierman, $1,410,028; Mr. Meier, $400,004; Ms. Davis, $391,074; Mr. Colpo, $284,894; Ms. den Hartog, $392,954; Mr. Shotto, $324,988.
Assumptions used in the calculation of the stock awards included in column (e) are included in note 12 to the consolidated financial statements included in the Companys Annual Report on Form 10-K for the year ended December 31, 2014, which is incorporated herein by reference. The actual value an NEO may receive for stock awards depends on market prices, and there can be no assurance that the amounts shown are the amounts that will be realized. Mr. Shotto forfeited all of his performance-based share awards upon his resignation from the Company effective August 31, 2014.
(2) The amounts included in column (g) reflect cash awards to the NEOs under the Companys performance-based annual incentive programs for 2014, 2013 and 2012. No awards were made under the 2014 Annual Incentive Program as discussed under Compensation Discussion and AnalysisAnnual Incentives on page 36 of this proxy statement.
(3) The amounts included in column (h) reflect the actuarial increase in the present value of the NEOs benefits under the Companys Supplemental Executive Retirement Plan (SERP) during 2014, 2013 and 2012 determined using interest rate and mortality rate assumptions consistent with those used in the Companys financial statements. SERP benefits were frozen effective March 31, 2012 and Mr. Meier does not participate in the SERP. For additional information on the Companys retirement plans, see Retirement Plans on page 51 of this proxy statement. No NEO received preferential or above-market earnings on deferred compensation.
(4) For 2014, the amounts included in column (i) consist of the following benefits or Company contributions attributable to the following:
Car Lease or Allowance |
Tax Planning/ Return Preparation |
Life Insurance Premiums |
Deferred Company Match |
Annual Physical/ Medical Access |
Other (a) |
Total | ||||||||||||||||||||||
Mr. Smith (b) |
$ | 14,317 | $ | 3,984 | $ | 30,875 | $ | 37,184 | $ | 950 | $ | 11,770 | $ | 99,080 | ||||||||||||||
Mr. Bierman |
9,600 | 7,000 | 0 | 19,249 | 950 | 1,430 | 38,229 | |||||||||||||||||||||
Mr. Meier (c) |
9,600 | 0 | 0 | 10,715 | 950 | 5,740 | 27,005 | |||||||||||||||||||||
Ms. Davis |
8,917 | 3,500 | 0 | 13,442 | 950 | 399 | 27,208 | |||||||||||||||||||||
Mr. Colpo (d) |
27,579 | 0 | 4,251 | 14,177 | 950 | 138,374 | 185,331 | |||||||||||||||||||||
Ms. den Hartog |
8,052 | 0 | 0 | 10,389 | 950 | 0 | 19,391 | |||||||||||||||||||||
Mr. Shotto (e) |
6,400 | 0 | 0 | 25,660 | 950 | 818,654 | 851,664 |
(a) | Unless otherwise provided with respect to an NEO, includes miscellaneous amenities and/or awards provided at Company sales and leadership conferences and other awards or gifts. |
(b) | Mr. Smiths other compensation includes $8,278 attributable to his personal use of Company-leased aircraft on one occasion during 2014. This amount represents the actual incremental cost incurred by the Company for the personal flight inclusive of fuel, trip-related maintenance and fees and pilot expenses. |
(c) | Mr. Meiers other compensation represents relocation compensation paid in 2014. |
(d) | Included in Mr. Colpos other compensation are the following amounts paid or attributed to him in connection with his temporary relocation to the United Kingdom to assist in managing our international |
46
logistics operations: $98,479 in local taxes paid on Mr. Colpos behalf, $22,489 in relocation expenses, $13,669 in an additional cost-of-living allowance, and $3,737 in relocation allowance. |
(e) | Mr. Shottos other compensation represents accrued vacation of $57,115 and a lump sum severance payment of $761,539 related to his resignation at the request of the Company. His lump sum severance payment was based on a negotiated 18-month severance period. For additional information on the Companys officer severance policy, see Severance Policy on page 56 of this proxy statement. |
(5) Mr. Smith served as Chairman & Chief Executive officer until September 1, 2014, at which time he was named Executive Chairman.
(6) Mr. Bierman was named President & Chief Executive Officer effective September 1, 2014. He served as President & Chief Operating Officer prior to his promotion.
(7) Mr. Meier joined the Company as Executive Vice President & Chief Financial Officer effective March 1, 2013.
(8) Mr. Shotto served as Senior Vice President, Manufacturer Services until his resignation from the Company effective August 31, 2014.
47
GRANTS OF PLAN BASED AWARDS TABLE
The following table shows awards granted to the named executive officers during the year ended December 31, 2014.
(a) | (b) | (c) | (d) | (e) | (f) | (g) | (h) | (i) | (j) | (k) | (l) | |||||||||||||||||||||||||||||
Name | Grant Date |
Estimated Future Payouts Under (1) |
Estimated Potential Payouts Under (2) |
All Other Stock Awards: Number of Shares of Stock or Units (3) (#) |
All Other Option Awards: Number of Securities Underlying Options (4) (#) |
Exercise or Base Price of Option Awards ($ /Sh) |
Grant Date Fair Value of Stock and Option Awards (5) |
|||||||||||||||||||||||||||||||||
Threshold ($) |
Target ($) |
Maximum ($) |
Threshold (#) |
Target (#) |
Maximum (#) |
|||||||||||||||||||||||||||||||||||
Craig R. Smith |
2/6/14 | | | | 1 | 11,912 | 23,824 | | | | $ | 400,005 | ||||||||||||||||||||||||||||
2/6/14 | | | | | | | 11,912 | | | 400,005 | ||||||||||||||||||||||||||||||
2/6/14 | | | | 1 | 6,081 | 12,162 | | | | 204,200 | ||||||||||||||||||||||||||||||
N/A | $ | 146,648 | $ | 586,593 | $ | 1,173,186 | | | | | | | | |||||||||||||||||||||||||||
James L. Bierman |
2/6/14 | | | | | | | 7,445 | | | $ | 250,003 | ||||||||||||||||||||||||||||
2/6/14 | | | | | | | 5,502 | | | 184,757 | ||||||||||||||||||||||||||||||
2/6/14 | | | | 1 | 7,445 | 14,890 | | | | 250,003 | ||||||||||||||||||||||||||||||
9/2/14 | | | | 1 | 13,285 | 26,570 | | | | 455,011 | ||||||||||||||||||||||||||||||
9/2/14 | | | | | | | 13,285 | | | 455,011 | ||||||||||||||||||||||||||||||
N/A | $ | 112,625 | $ | 450,500 | $ | 901,000 | | | | | | | | |||||||||||||||||||||||||||
Richard A. Meier |
2/6/14 | | | | 1 | 5,956 | 11,912 | | | | $ | 200,002 | ||||||||||||||||||||||||||||
2/6/14 | | | | | | | 5,956 | | | 200,002 | ||||||||||||||||||||||||||||||
2/6/14 | | | | | | | 2,692 | | | 90,397 | ||||||||||||||||||||||||||||||
N/A | $ | 73,313 | $ | 293,250 | $ | 586,500 | | | | | | | | |||||||||||||||||||||||||||
Erica T. Davis |
2/6/14 | | | | 1 | 4,839 | 9,678 | | | | $ | 162,494 | ||||||||||||||||||||||||||||
2/6/14 | | | | | | | 4,839 | | | 162,494 | ||||||||||||||||||||||||||||||
2/6/14 | | | | 1 | 984 | 1,968 | | | | 33,043 | ||||||||||||||||||||||||||||||
N/A | $ | 63,113 | $ | 252,450 | $ | 504,900 | | | | | | | | |||||||||||||||||||||||||||
Charles C. Colpo |
2/6/14 | | | | 1 | 3,127 | 6,254 | | | | $ | 105,005 | ||||||||||||||||||||||||||||
2/6/14 | | | | | | | 3,127 | | | 105,005 | ||||||||||||||||||||||||||||||
2/6/14 | | | | 1 | 1,115 | 2,230 | | | | 37,442 | ||||||||||||||||||||||||||||||
N/A | $ | 54,360 | $ | 217,440 | $ | 434,880 | | | | | | | | |||||||||||||||||||||||||||
Grace den Hartog |
2/6/14 | | | | 1 | 4,839 | 9,678 | | | | $ | 162,494 | ||||||||||||||||||||||||||||
2/6/14 | | | | | | | 4,839 | | | 162,494 | ||||||||||||||||||||||||||||||
2/6/14 | | | | 1 | 1,012 | 2,024 | | | | 33,983 | ||||||||||||||||||||||||||||||
N/A | $ | 55,625 | $ | 222,500 | $ | 445,000 | | | | | | | | |||||||||||||||||||||||||||
Brian J. Shotto |
2/6/14 | | | | 1 | 4,839 | 9,678 | | | | $ | 162,494 | ||||||||||||||||||||||||||||
2/6/14 | | | | | | | 4,839 | | | 162,494 | ||||||||||||||||||||||||||||||
2/6/14 | | | | | | | 1,396 | | | 46,878 | ||||||||||||||||||||||||||||||
N/A | $ | 41,250 | $ | 165,000 | $ | 330,000 | | | | | | | | |||||||||||||||||||||||||||
(1) The amounts shown in column (c) reflect the minimum payment level under the Companys 2014 Annual Incentive Program if minimum performance conditions were met and represents 25% of the target payment level shown in column (d) which is based on meeting target performance conditions. The amount shown in column (e) is 200% of the target payment level and is based on meeting maximum performance conditions. These amounts are based upon the individuals 2014 salary and position (75% of base salary for the Chief Executive Officer and 50% of base salary for the other named executive officers). There were no payouts under the 2014 Annual Incentive Program as reflected in Summary Compensation TableNon-Equity Incentive Plan Compensation.
48
(2) The amounts shown in column (f) reflect the minimum restricted stock award level under 2014 performance share grants if minimum performance conditions are met and represents the minimum level of growth in operating earnings. The target restricted stock award level shown in column (g) is based on meeting target performance conditions and (h) is 200% of the target restricted stock award level and is based on meeting the maximum performance conditions. These restricted stock awards are based on the Companys achievement of growth in operating earnings goals for 2014 and 2015 as discussed on page 40 of this proxy statement and, if earned, vest on the third anniversary of the performance share grant. Dividends are not paid on performance share grants unless and until the performance conditions are satisfied, resulting in the issuance of the underlying restricted stock.
(3) The amounts shown in column (i) represent grants of restricted stock that vest either three or five years from the date of grant based on the executives continued employment with the Company. Dividends are paid on outstanding restricted stock grants at the same rate as for all shareholders of record.
(4) No stock options were granted by the Company in 2014.
(5) The amounts shown in column (l) are the grant date fair value of each individual equity award computed in accordance with FASB ASC Topic 718.
49
OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END TABLE
The following table summarizes for each NEO information regarding unexercised stock options, unvested restricted stock awards and incentive plan awards outstanding as of December 31, 2014.
Option Awards | Stock Awards | |||||||||||||||||||||||||||||||||||
(a) | (b) | (c) | (d) | (e) | (f) | (g) | (h) | (i) | (j) | |||||||||||||||||||||||||||
Number of Securities Underlying Unexercised Options (#) |
Number of Securities Underlying Unexercised Options (#) |
Equity (#) |
Option Exercise Price ($) |
Option Expiration Date |
Number of (#) (1) |
Market ($) (2) |
Equity or Other Rights (#) (3) |
Equity ($) (3) |
||||||||||||||||||||||||||||
Name | Exercisable | Unexercisable | ||||||||||||||||||||||||||||||||||
Craig R. Smith |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,912 13,068 14,867 |
|
$
|
418,230 458,817 521,980 |
|
|
11,912 6,081 |
|
|
418,230 213,504 |
| |||||||||
Total |
| | | | | 39,847 | 1,399,028 | 17,993 | 631,734 | |||||||||||||||||||||||||||
James L. Bierman |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,285 7,445 5,502 5,988 8,167 4,183 7,847 1,678 2,734 2,565 |
|
$
|
466,436 261,394 193,175 210,239 286,743 146,865 275,508 58,915 95,991 90,057 |
|
|
7,445 13,285 |
|
|
261,394 466,436 |
| |||||||||
Total |
| | | | | 59,394 | 2,085,323 | 20,730 | 727,830 | |||||||||||||||||||||||||||
Richard A. Meier |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,956 2,692 16,420 9,852 |
|
$
|
209,115 94,516 576,506 345,904 |
|
|
5,956 |
|
|
209,115 |
| |||||||||
Total |
| | | | | 34,920 | 1,226,041 | 5,956 | 209,115 | |||||||||||||||||||||||||||
Erika T. Davis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,839 3,760 5,309 5,633 |
|
$
|
169,897 132,014 186,399 197,795 |
|
|
4,839 984 |
|
|
169,897 34,548 |
| |||||||||
Total |
| | | | | 19,541 | 686,085 | 5,823 | 204,446 | |||||||||||||||||||||||||||
Charles C. Colpo |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,127 3,267 3,717 |
|
$
|
109,789 114,704 130,504 |
|
|
3,127 1,115 |
|
|
109,789 39,148 |
| |||||||||
Total |
| | | | | 10,111 | 354,997 | 4,242 | 148,937 | |||||||||||||||||||||||||||
Grace R. den Hartog |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,839 5,309 5,633 |
|
$
|
169,897 186,399 197,775 |
|
|
4,839 1,012 |
|
|
169,897 35,531 |
| |||||||||
Total |
| | | | | 15,781 | 554,071 | 5,851 | 205,429 | |||||||||||||||||||||||||||
Brian J. Shotto (4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,773 1,211 2,876 2,340 310 593 |
|
$
|
132,470 42,518 100,976 82,157 10,884 20,820 |
|